US20140323884A1 - Passive physiological monitoring (p2m) system - Google Patents

Passive physiological monitoring (p2m) system Download PDF

Info

Publication number
US20140323884A1
US20140323884A1 US14/334,595 US201414334595A US2014323884A1 US 20140323884 A1 US20140323884 A1 US 20140323884A1 US 201414334595 A US201414334595 A US 201414334595A US 2014323884 A1 US2014323884 A1 US 2014323884A1
Authority
US
United States
Prior art keywords
patient
signals
sensor
sensors
physiological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/334,595
Inventor
Patrick K. Sullivan
Ken C.K. Cheung
Christopher J. Sullivan
Paul Pernambuco-Wise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoana Medical Inc
Original Assignee
Hoana Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoana Medical Inc filed Critical Hoana Medical Inc
Priority to US14/334,595 priority Critical patent/US20140323884A1/en
Publication of US20140323884A1 publication Critical patent/US20140323884A1/en
Priority to US14/960,246 priority patent/US20160157734A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/02108Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • A61B5/02125Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave propagation time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/113Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb occurring during breathing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0247Pressure sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04Arrangements of multiple sensors of the same type
    • A61B2562/043Arrangements of multiple sensors of the same type in a linear array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7253Details of waveform analysis characterised by using transforms
    • A61B5/7257Details of waveform analysis characterised by using transforms using Fourier transforms

Definitions

  • Vital signs monitoring is normally a simple and routine procedure involving collection of pulse, respiration and blood pressure data. In a relatively quiet environment, these parameters are easily detected.
  • acquisition of physiological signals of interest in a helicopter environment is a challenging problem for several reasons.
  • Limitations on vital signs collection include high noise, vibration, auditory distractions, ineffective monitoring equipment, cramped working conditions, bulky gear during air evacuation, and electromagnetic interference with aircraft systems caused by some medical equipment.
  • the additional complexity of leads and electrodes compounds the noise and environmental problems.
  • the physiological parameters of vital signs fall within the helicopter-generated frequencies. Helicopter frequencies have a much greater power in those frequencies as well. Vibrational and acoustic artifacts are also major problems.
  • the signal to noise problem must therefore be solved by other means in addition to low and high band pass filtering approaches. Due to the limiting work conditions, medical personnel cannot use a stethoscope to accurately monitor heart activity or blood pressure.
  • the military medical system needs a portable, non-invasive device capable of monitoring a soldier's vital signs in the field environment under less than ideal circumstances.
  • This system needs to be useful to military medical personnel across the spectrum of care delivery, such as in mass casualty situations, aeromedical evacuations, ground ambulance transports, hospital wards, and intensive care units.
  • a recent study found that thirty-two percent of aircraft medical devices flown onboard a rotor-wing MEDEVAC aircraft failed at least one environmental test.
  • Quartz crystals are minerals that create an electric field known as piezoelectricity when pressure is applied. Materials scientists have found other materials with piezoelectric properties. The versatility and potential uses for piezoelectric materials have been known but cost-prohibitive for some time.
  • piezoelectric-based instrumentation The medical practice and research application of piezoelectric-based instrumentation is gaining momentum.
  • Piezoelectric methods have been successfully used in plethysmography, blood pressure monitoring by piezoelectric contact microphone, heart rate monitoring in avian embryos and hatchlings and piezoelectric probes.
  • Piezoelectric materials are used as detectors of sensitive motion to measure human tremor, small body movements of animals in response to pharmacological manipulation, and respiratory motion for nuclear magnetic resonance (NMR) animal experiments.
  • NMR nuclear magnetic resonance
  • piezoelectric methods In combination with ultrasound, piezoelectric methods have been used to assess coronary hemodynamics, elastic tensor, intra-arterial imaging, and receptor field dimensions.
  • piezoelectric transducers have been attached to the chest wall and used with automated auscultation devices and microcomputers for lung sound analysis.
  • Piezoelectric film has been applied and studied to determine joint contact stress
  • piezoelectric disks have been used for recording muscle sounds and qualitative monitoring of the neuro
  • Stochastic wave theory as commonly used in ocean engineering to analyze pseudo-periodic phenomena, indicates spectral peaks from respiration and heart rate.
  • Human heartbeats, respiration, and blood pressure are repetitive in nature, reflecting complex mechano-acoustical events.
  • various problems with piezoelectric instrumentation development prevent its full realization. Measurement of human tremor only works well when the environment is absolutely silent. In fact, extraneous noise such as equipment, fans, people talking, and the patient's own voice routinely exists in most hospital rooms. That noise masks and distorts the signal of interest, thus limiting the practicality of piezoelectric instrumentation. Animal noises make data collection difficult in laboratory animal studies. In non-laboratory environments, medical uses of piezoelectric instrumentation for humans remains a problem because of the inherent signal-noise problem.
  • a primary mission of military nurses is to ensure that wounded and sick soldiers obtain prompt medical attention and/or evacuation to definitive medical care.
  • the actions performed during the time period between a battlefield injury and the transfer of casualties to appropriate medical treatment is critical for the welfare of the soldier, and can be the difference between life and death. It is during this critical time period where diagnosis and treatment begins and also when evacuation—for example via MEDEVAC helicopter—occurs.
  • monitor that can consistently and accurately measure vital signs during a medical evacuation where there is high noise and vibration.
  • the monitor being relatively autonomous intervention by a nurse or technician is not required.
  • information may be forwarded in real-time via wireless communication to the destination where medical personnel and other caregivers are located.
  • the present invention is known as Passive Physiological Monitoring, P 2 M, or simply P2M.
  • Data records with vast information, such as blood pressure, are measured, recorded, and may later be delineated to determine the physical condition of the subject being monitored.
  • the cardiovascular system is modeled as a system of pipes, pumps, and other appendices, with the engineering phenomenon known as “water hammer” as the basis for a working model for data analysis in the calculation of blood pressure.
  • Water hammer is a compression wave transmitted through the household plumbing network of pipes and valves when household water is abruptly shut off. The result is a noticeable sound and the deterioration of the plumbing system. Water hammer is caused by the increase in pipe pressure caused by sudden velocity change, typically after water is shut off during a valve closing.
  • the compression wave is described as follows:
  • Skalak (1966) applied the linearized theory of viscous flow to develop a basis for understanding the main waveform features in arteries and veins.
  • the vascular system is equivalent to a network of non-uniform transmission lines.
  • Karr (1982) studied pressure wave velocity on human subjects and developed a method to determine the pulse propagation speed. The invention recognizes that such information may be used to determine plaque buildup, cholesterol concentration on the arterial wall, and arterial wall thickness.
  • Equation (1) allows for determination of pressure change (dP) from the heart pulsing based on the dispersion relationship between pulse wave velocity (c) and flow velocity (v).
  • Karr's method measures flow velocity to determine dP, which is related to systolic pressure (pS) and diastolic pressure (pD).
  • the new invention measures the pressure energy from heartbeat and respiration collectively.
  • the heart contribution to the energy spectrum is determined by removing the respiration contribution to the energy spectrum.
  • Respiration energy is filtered out by comparing the energy spectrum calculations of velocity with velocity measures using electromagnetic and doppler methods.
  • the new monitor can be configured for one of its piezoelectric sensors to serve as a dedicated doppler sensor that uses ultrasonics to adjust interpretations of data as a function of the sympathetic tone of the patient.
  • the selective omission of P2M signals and the selective comparison of P2M sensor data with data from other parts of the body, as well as comparisons between two or more simultaneously triggered sensors isolates energy contributions from the heart.
  • P2M energy spectra determined from the foot differs from spectra derived from the chest area, which provides a means for isolating heart energy as the foot spectra is largely void of energy from respiration.
  • h height, head energy term.
  • P2M is well-suited to assist medical personnel in several areas including, but not limited to, the following situations:
  • the development of the P2M or a passive sensor array is a significant innovation in passive monitoring.
  • a grid of passive sensors noise can be reduced through correlating signals from different pads to discern noise from biological signals. This is very important in high-noise environments.
  • the significance of a passive multi-sensor system is that it affords the opportunity to more comprehensively monitor a patient.
  • the grid of passive sensors provides an innovative way to monitor patients in adverse ambient conditions.
  • the system provides a tool whereby parameters other than blood pressure, heart rate, and respiration can be measured. These parameters include, but are not limited to, patient movement and sleep habits, pulse strength over various portions of the body, relative blood flow volumes, and cardiac output, among others.
  • the main components of the Passive Physiological (P 2 M) system are the passive sensor, hardware for amplification, filtering, data-acquisition, and signal-analysis software.
  • the single passive sensor has dimensions 8′′ ⁇ 10′′ and is preferably encased in a protective covering. Leads from the sensor attach to the electronics (amplifier, filter, data-acquisition card, desktop computer) where the raw analog voltage signal is filtered and amplified and converted to digital form. Digital filtering and software manipulation of the data in the form of frequency analyses are then performed. Finally, signal processing techniques are then used to extract physiological information from the digital signal.
  • the sensor pad is preferably placed directly beneath the back of a patient lying supine on a MEDEVAC litter.
  • the mechanical/acoustic signals created by cardio-pulmonary function are transmitted through the body onto the passive sensor, which converts the signal into an analog voltage.
  • An illustration of the existing P2M setup is shown in FIG. 6 .
  • the major hardware used for the laboratory setup are: desktop computer, a multi-function programmable charge amplifier and roll-around rack to encase all of the hardware. To maintain versatility for initial research and development, most of the equipment were chosen for functionality at the expense of space efficiency.
  • the variables of accuracy, precision, user characteristics, and patient comfort determine the value of a field instrument for collection data on vital signs.
  • FIG. 1 is a schematic of the P2M system components.
  • FIG. 2 is a perspective view of the P2M system.
  • FIG. 3 is a graphical comparison of the P2M bench test results and the human evaluator measurements.
  • FIG. 4 is a front view of the front panel display and user interface of the P2M system in Acquire Mode.
  • FIG. 5 is a front view of the front panel display of the P2M system in Monitor Mode.
  • FIG. 6 is a schematic view of a preferred embodiment of the P2M sensor.
  • FIG. 7 shows one of the graphical user interfaces (GUI) of the P2M system.
  • FIG. 8 shows the graphical user interface of the P2M system showing time-series and frequency-domain representations of physiological data.
  • FIG. 9 shows measurement of Pulse-Wave Travel Time (PWTT)
  • FIG. 10 shows a system test and evaluation results in a graph.
  • FIG. 11 high noise and vibration testing of the P2M at Wheeler Army Air Field.
  • FIG. 12 shows the measurement through a body armor.
  • FIG. 13 shows testing through body armor and MOPP gear combined.
  • FIG. 14 shows a schematic view of the Passive Physiological Monitoring (P2M) System Using a passive sensor array and microelectronics incorporated into a MEDEVAC litter.
  • P2M Passive Physiological Monitoring
  • the preferred P2M system is a monitoring device with two major subsystems, one to measure signals and the other to process data into meaningful information.
  • FIG. 1 shows a schematic of the system
  • FIG. 2 shows a perspective view of the system.
  • the piezoelectric film, an electrically active fluoropolymer converts mechanical energy such as movement caused by a heartbeat into voltage measurements capable of supporting time series analysis techniques.
  • the voltage is recorded by and analyzed using a microcomputer controlled system, the purpose of which is to discriminate the signal from background noise and display it on a screen or printout.
  • Techniques such as preamplifying and preconditioning through the use of high and low-band pass filters reduces noise.
  • the piezoelectric material 1 used is the polymer polyvinylidene fluoride (PVDF), which can be shaped into cables, thin film, or thick tiles.
  • PVDF piezoelectric film is environmentally rugged, lightweight, flexible, inherently reliable, sturdy, easily repairable and transportable with excessive assembly or disassembly. Since the material is inert, it may be used inside the human body. Ultraviolet radiation passes harmlessly through the PVDF film, which may be produced in varying thicknesses. In addition, the piezoelectric film is waterproof, operates between 0 and 145 degrees Centigrade, and does not tear under stress. PVDF may convert a temperature reading into an electric output.
  • the PVDF film is incorporated into a fluid-filled vinyl pad, approximately 10 cm by 10 cm in surface area. This is placed on/under/above various locations of the patient.
  • the piezoelectric element 1 is a pressure-sensing detector acting as a highly sensitive strain gage providing high dynamic range and linearity.
  • Analog signals are fed through a band-pass filter into an amplifier ( ⁇ 200- ⁇ 5000) 5 and are visually displayed.
  • Analog acoustic signals are converted to digital values using a multi-channel converter 7 at a sampling rate of up to 5 kHz. Data is transformed to the frequency domain using Fast Fourier Transform (FFT).
  • FFT Fast Fourier Transform
  • PVDF piezoelectric film 1 acts as a piezoelectric strain gage.
  • the voltage output is up to four orders of magnitude higher than that produced by a nonamplified signal from circuitry used with resistive wire. Linearity and frequency response are excellent.
  • current need not be applied since the device is electrically self-generating.
  • the present invention does not produce an electric charge ad infinitum with sustained stress.
  • the slowest frequency the polymer film detects is a thousand seconds for an electrical event to occur, and the highest is one gigahertz (microwave).
  • the piezoelectric film is passive and biologically non-hazardous, as opposed to traditional strain gages that require an applied current.
  • PVDF sheets are commercial off-the-shelf (COTS) products, the type and specifications of which were chosen based on optimum sensitivity range and resilience. Each sheet contains seven-foot attached shielded twisted-pair (for noise rejection) leads 11 to transmit the charge produced by the sheets.
  • COTS commercial off-the-shelf
  • the piezoelectric sheets 1 are placed under a patient's chest and foot or at similarly remote areas of the body, or may be put on like a wrapped cuff.
  • the change in pressure exerted by the patient's respiration and heartbeat causes the piezoelectric film to generate voltages, which is carried via nonmagnetic miniature coaxial cable 11 through a radio frequency filter 13 .
  • the signal is then directed to a high input-impedance amplifier 5 and computer system 7 for data processing.
  • a conventional oscilloscope and a chart recorder displays the output. Respiration and heart rate 15 are then calculated by the energy spectrum from the time series data.
  • signal processing techniques that use a prior knowledge of the expected signals extract the desired information from the piezoelectric signal. Spectral techniques help to identify the frequencies and amplitudes of the events of interest and discern them from extraneous noise.
  • Cardiac action analysis uses a bandpass frequency limit of 0.1-4.0 Hz
  • respiration analysis uses a frequency limit from 0.01-3.0 Hz.
  • the filtered cardiac and respiration signals are fed to a recording system.
  • Body movements are analyzed by bandpass filtering the original signal with frequency limits from 0.1-20 Hz.
  • the hardware equipment includes, but is not limited to, a 586 processor computer 9 with enhanced RAM and disk capacity to handle large amounts of data.
  • a board with a range that includes acoustic frequencies facilitates data acquisition, signal conditioning and signal processing.
  • a master program 17 combines the three separate software modules of data acquisition/control, signal processing/analysis, and data display/user interface.
  • the LabVIEWTM “G” graphical programming language was used for all three subroutine programs.
  • the analog voltage signal is digitized and analyzed in time and frequency domains. Routines developed for signal conditioning and analysis include digital filtering, spectral analysis, auto correlation, and noise-rejection programs.
  • the data is displayed real-time in either Monitor or Acquisition mode. Monitor mode displays the current data and discards old readings as new updates are processed, while Acquisition mode saves data for future analysis.
  • the voluminous data must not exceed the disk-storage capacity of the computer in Acquisition mode.
  • the entire P2M system 19 is encased in a metal technical enclosure 21 with casters (not shown) and locking glass door (not shown), as shown in FIG. 2 .
  • the equipment also includes a MEDEVAC stretcher 23 on which the sensor is mounted. This device may be incorporated into a litter to eliminate the need for patient attachment or miniaturized as a portable field device in a purse with a wireless communication setup.
  • the piezoelectric film measures mechanical, thermal and acoustic signals. That high sensitivity is necessary to measure vital signals non-intrusively.
  • pulse rate the physical beating of the heart is transmitted through the body into the piezo-film sensor pad as mechanical impulses.
  • the respiration is measured by the mechanical impulse transmitted to the sensor based on chest movements.
  • the sensitive piezo-film sensor pad measures all extraneous movement and speech, resulting in a voltage signal output that is superimposed upon the physiological signals. As a result, movement or speech by the subject may cause a reading error.
  • the P2M sensor measures all physical impulses in the measuring environment, including the patient's physiological signals, nearby human noise and activity signals, noise and vibration from the machinery, and electromagnetic (EM) noise emitted from the lights and instrumentation. While the output signal includes all of these signals, many are too weak to affect the measurement while others such as EM noise corrupt the reading.
  • Running the signal through filters and other signal-processing algorithms removes the noise.
  • the conditioned signal is then analyzed through routines, including a fast Fourier transform (FFT) which identifies the primary signal frequencies. For a still, speechless patient, the primary frequency is usually respiration, and the second highest frequency is heart rate. Patient positioning and frequency harmonics may complicate the distinction, requiring additional logic to separate and identify the heart and respiration frequency peaks.
  • the logic algorithms must be robust enough to define the respiration and heart peaks for a variety of conditions.
  • the minimum sampling interval was thirty seconds.
  • FIG. 3 shows the results for the twenty respiration/pulse-rate measurements performed with the P2M system. Human evaluator measurements were performed simultaneously as a control. P2M accurately measured pulse 25 and respiration 27 under ideal conditions, but patient movement or speech interfered with accurate measurement. Heart rate measurement quality was not reduced by the absence of respiration, and P2M matched the control measurement results 29 , 31 with an error of less than beat per minute.
  • FIG. 4 shows the P2M front panel in Acquisition mode.
  • the upper graph 33 displays a thirty-second window of time-series measurements of all physiological signals. Heartbeat spikes are shown in the upper (time series) graph 33 , along with a lower-frequency sinusoidal function which corresponds to the respiration signal.
  • the lower graph 35 shows the same data in the frequency domain.
  • the first and largest spike 37 corresponds to approximately 16.4 respirations per minute.
  • the control group 31 measured 17 ⁇ 2 respirations per minute.
  • the large amplitude of the spike indicates that respiration is the largest impulse measured by the sensor pad.
  • the second-largest spike 39 is sixty times per minute, which was identical to the actual heart rate measured by a fingertip-clip heart-rate monitor.
  • the power as measured by the amplitude is less than one-third of that found in the respiration frequency, but the ratio varies based on the physiology and sensor pad positioning of the patient.
  • the smaller spikes 41 in the lower graph represent respiration and heart-rate harmonics, a result of the harmonics not being a perfect sinusoidal function. Since the heart rate might fall at exactly the same frequency as a respiration harmonic, it is necessary for logic algorithms to check for harmonics.
  • the heart rate and respiration harmonics may be differentiated by comparing signals taken from different parts of the body.
  • buttons and menus 43 on the front panel of the interface program enables the control of data acquisition and analysis routines.
  • the thirty-second data records may be saved to file for archiving or additional evaluation.
  • FIG. 5 shows the P2M system in Monitor mode.
  • the top graph 45 shows the time-series data, with the characteristic higher-frequency heartbeat spikes 47 superimposed over a lower-frequency respiration wave 49 .
  • the middle graph 51 shows heart rate 53 and respiration 55 as updated every five seconds. As a new five-second data string is acquired, the oldest five seconds of data is discarded, and the heart rate and respiration are re-calculated by analyzing the thirty-second data string with the new data.
  • the upper curve 53 is colored red to signify heart rate, while the lower curve 55 is colored blue to signify respiration. Heart rate appears steady in the mid-50s range, with respiration in the mid-teens. Both compare favorably ( ⁇ 2) with human control measurements.
  • the anomaly 57 after 25 updates is attributable to patient movement or an extraneous and errant noise/vibration event.
  • the bottom graph 59 shows an FFT of the time-series signal.
  • Regular voltage signals of heart beat provide strength signals as voltage levels that are related to blood pressure. Times between signals at varied parts of the body or patterns of secondary signals provide information on circulation or blockage or interference with blood flow.
  • FIG. 6 shows a schematic view of the P2M system with a single passive sensor 61 positioned on a patient 63 .
  • FIG. 7 shows one of the graphical user interfaces (GUI) of the P2M system.
  • the upper chart 65 shows a 30-second window of digital voltage data, where the low-frequency oscillations are caused by respiration and the higher-frequency spikes are the result of heartbeat measurements of the patient on the litter.
  • the time-series signal is converted to frequency data via a Fourier transform and displayed as a power spectrum, shown in the middle chart 67 . From this data, pulse and respiration can be extracted by examining the power associated with the dominant frequencies 69 .
  • passive measurement of blood pressure may be conducted using pulse wave analyses.
  • PWV pulse-wave velocity
  • PWTT pulse-wave travel time
  • the sensors may measure pulse-wave characteristics, for example, along the brachial artery, along with other measurements described herein.
  • FIG. 8 shows measurement results of the pulse at two locations along the arm.
  • the temporal separation between the two corresponding peaks 71 , 73 gives the Pulse-Wave Travel Time (PWTT).
  • PWTT Pulse-Wave Travel Time
  • FIG. 9 shows a photograph of the testing performed at TAMC. A total of 11 volunteers were monitored following the project's testing protocol.
  • FIG. 10 displays the results of the testing.
  • the P2M was over 95% accurate as compared to conventional methods, and the several instances where the P2M was not in agreement with conventional methods proved to be very valuable in subsequent modifications and improvements to the system software.
  • 12 volunteer nurses performed physiological monitoring of pulse and respiration using the P2M, electronic monitor, and human evaluation. Following the monitoring, the nurses completed a survey comparing and ranking the usage of the three methods.
  • FIG. 11 shows the high noise and vibration testing of P2M at Wheeler Army Air Field, on Mar. 5, 1999.
  • the single-sensor PN configuration that has been demonstrated to accurately measure pulse and respiration is very sensitive to the patient position relative to the main sensor pad.
  • the quality and magnitude of the physiological signals received by the system depends on this positioning.
  • the preferred optimum placement is to situate the sensor directly beneath the center of the patient's chest. If the sensor is moved from this placement, or if the patient position changes, the integrity of the incoming signal also changes.
  • a preferred configuration uses multiple sensors in a pattern that covers the entire region of the litter on which the patient would lie so that regardless of patient movement and position, there will always be one or more active sensors in optimum measurement placements.
  • the invention is a passive system using an array of distributed sensors (or “multi-sensor”) capable of accurately and robustly monitoring certain physiological signals of the human body. These signals, in turn, may be processed for determination of vital signs that are currently used by nurses and other caregivers, for example, heart rate, respiration, and systolic/diastolic blood pressure.
  • the invention uniquely provides a device that is passive (completely non-invasive), unobtrusive, and autonomous; i.e., the apparatus in no way interferes either with the patient's mobility or with other monitoring equipment, and is capable of functioning with a minimum of technical expertise.
  • the equipment functions reliably in high-noise environments and other situations that render alternative and existing methods ineffective. These environments include, but are not limited to, medical evacuation (MEDEVAC) by helicopter or ambulance, and operation through Military Oriented Protective Posture (MOPP) gear and body armor.
  • MEDEVAC medical evacuation
  • MOPP Military Oriented Protective Posture
  • FIG. 14 shows a schematic of the P2M using a passive sensor array and microelectronics incorporated into a MEDEVAC litter.
  • a schematic of the inventive technology, incorporated into a MEDEVAC litter, is shown in FIG. 14 below.
  • the litter 75 is covered in an array 77 of 32 sensors, each of which can measure acoustic and hydraulic inputs from the patient 63 .
  • Each of these signals contains a measure of physiologically generated signal and environmental noise.
  • the environmental noise on each pad will be similar, whereas the physiologically generated signals may be position dependent. This information is used to separate the signal from the noise using proven techniques.
  • Position dependent physiological signals are used to determine patient position, heart rate, respiration, blood pressure, pulse strength distribution, and potentially some measure of cardiac output.
  • the invention may be incorporated into a wide range of applications apart from the MEDEVAC litter.
  • the passive sensor array may be configured without much change to operate on a hospital bed or an ordinary mattress used at home. Of particular note is the area of premature infant care. In this case, the attachment of sensor leads to the infant may often be difficult, causing irritation of sensitive skin and entanglement in leads.
  • the sensor may be incorporated into equipment for use in both civilian and military sectors.
  • the sensor may be incorporated into field equipment, clothes and uniforms. This includes, but is not limited to, cervical collars, body armor, biological and/or chemical hazard protection suits, extraction devices, clothes, cushions on seats and seatbacks.
  • Exercise equipment such as stationary bicycles, treadmills or steppers may benefit by incorporating sensors into the supports.
  • Physiological indicators such as heart rate may be detected through handholds as an aid to regulating the exercise regime.
  • Other useful applications might include the use of a passive sensor system in a chair or couch used for psychological examinations. Scrutiny of the subject's physiological signs may give indications of emotional disturbance caused by trigger words or events during counseling.
  • the size of each sensor, number of sensors in the array, and configuration of the sensor array may be tailored, without much experimentation, to particular needs and situations. For a mattress, for example, 32 or more sensors in a rectangular array may be required.
  • the preferred passive sensor may use piezo-electric films and ceramics, hydrophones, microphones or pressure transducers.
  • Amplification hardware may include signal amplification circuitry and hardware, e.g., charge amplifier.
  • Data acquisition hardware and signal processing hardware (circuitry) and software are used in the system.
  • solid, fluidized (air) or fluid layer may be used, as for example, gel, water, foam, rubber, plastic, etc. The interface facilitates transmittal of physiological signals.
  • the invention has great medical value for field monitoring, hospital monitoring, transport monitoring, and home/remote monitoring.
  • the invention may have application in every hospital for passive monitoring of patients.
  • the invention being undetectable to the patient, which adds comfort to the monitoring process.

Abstract

Passive physiological monitoring apparatus and method has a sensor for sensing physiological phenomenon. The sensor is a piezoelectric film of polyvinylidene fluoride. A pad may incorporate the PVDF film. The film converts mechanical energy into voltage signals. A microcomputer is used for recording, analyzing and displaying data from the sensor for on-line assessment and for providing realtime response. The sensor may be an array of sensors provided in a MEDEVAC litter or other patient support for measuring acoustic and hydraulic signals from the body of a patient for field monitoring, hospital monitoring, transport monitoring, home, remote monitoring.

Description

    BACKGROUND OF THE INVENTION
  • Minimization of the time between injury occurrence and transport to the appropriate level of medical care is necessary to ensure that wounded and sick soldiers obtain the prompt medical attention essential for their survival. During that time, aeromedical care in a MEDEVAC helicopter environment is used to identify and transport casualties.
  • Military units conduct aeromedical evacuations daily during times of war and peace, exposing the patient and flight/medical crew to noise or environmental stress and difficult monitoring conditions. As in the civilian community, military nurses depend on reliable and efficient monitoring devices to provide accurate patient care in various environments, some of which are hostile and obtrusive to the use of conventional monitoring instrumentation. While aeromedical evacuation is a life-saving process for many, it is nearly impossible for medical personnel to monitor vital signs in a high noise environment.
  • Vital signs monitoring is normally a simple and routine procedure involving collection of pulse, respiration and blood pressure data. In a relatively quiet environment, these parameters are easily detected. However, acquisition of physiological signals of interest in a helicopter environment is a challenging problem for several reasons. Limitations on vital signs collection include high noise, vibration, auditory distractions, ineffective monitoring equipment, cramped working conditions, bulky gear during air evacuation, and electromagnetic interference with aircraft systems caused by some medical equipment. The additional complexity of leads and electrodes compounds the noise and environmental problems. The physiological parameters of vital signs fall within the helicopter-generated frequencies. Helicopter frequencies have a much greater power in those frequencies as well. Vibrational and acoustic artifacts are also major problems. The signal to noise problem must therefore be solved by other means in addition to low and high band pass filtering approaches. Due to the limiting work conditions, medical personnel cannot use a stethoscope to accurately monitor heart activity or blood pressure.
  • The military medical system needs a portable, non-invasive device capable of monitoring a soldier's vital signs in the field environment under less than ideal circumstances. This system needs to be useful to military medical personnel across the spectrum of care delivery, such as in mass casualty situations, aeromedical evacuations, ground ambulance transports, hospital wards, and intensive care units. A recent study found that thirty-two percent of aircraft medical devices flown onboard a rotor-wing MEDEVAC aircraft failed at least one environmental test.
  • Quartz crystals are minerals that create an electric field known as piezoelectricity when pressure is applied. Materials scientists have found other materials with piezoelectric properties. The versatility and potential uses for piezoelectric materials have been known but cost-prohibitive for some time.
  • However, recent decreases in the cost of manufacturing now permit greater application by engineers and researchers. The advantageous qualities of piezoelectric materials have been applied to medicine, security, acoustics, defense, geology and other fields. Development of applications with piezoelectric materials is in its infancy.
  • The medical practice and research application of piezoelectric-based instrumentation is gaining momentum. Piezoelectric methods have been successfully used in plethysmography, blood pressure monitoring by piezoelectric contact microphone, heart rate monitoring in avian embryos and hatchlings and piezoelectric probes. Piezoelectric materials are used as detectors of sensitive motion to measure human tremor, small body movements of animals in response to pharmacological manipulation, and respiratory motion for nuclear magnetic resonance (NMR) animal experiments. In combination with ultrasound, piezoelectric methods have been used to assess coronary hemodynamics, elastic tensor, intra-arterial imaging, and receptor field dimensions. In addition, piezoelectric transducers have been attached to the chest wall and used with automated auscultation devices and microcomputers for lung sound analysis. Piezoelectric film has been applied and studied to determine joint contact stress, and piezoelectric disks have been used for recording muscle sounds and qualitative monitoring of the neuromuscular block.
  • Stochastic wave theory, as commonly used in ocean engineering to analyze pseudo-periodic phenomena, indicates spectral peaks from respiration and heart rate. Human heartbeats, respiration, and blood pressure are repetitive in nature, reflecting complex mechano-acoustical events. However, various problems with piezoelectric instrumentation development prevent its full realization. Measurement of human tremor only works well when the environment is absolutely silent. In fact, extraneous noise such as equipment, fans, people talking, and the patient's own voice routinely exists in most hospital rooms. That noise masks and distorts the signal of interest, thus limiting the practicality of piezoelectric instrumentation. Animal noises make data collection difficult in laboratory animal studies. In non-laboratory environments, medical uses of piezoelectric instrumentation for humans remains a problem because of the inherent signal-noise problem.
  • A primary mission of military nurses is to ensure that wounded and sick soldiers obtain prompt medical attention and/or evacuation to definitive medical care. The actions performed during the time period between a battlefield injury and the transfer of casualties to appropriate medical treatment is critical for the welfare of the soldier, and can be the difference between life and death. It is during this critical time period where diagnosis and treatment begins and also when evacuation—for example via MEDEVAC helicopter—occurs.
  • Unfortunately, the extremely high noise and vibration inherent in the helicopter environment prevents nursing and medical personnel from accurately measuring vital signs. Not only are electronic medical monitors rendered ineffective with the high vibrations; traditional methods of measuring pulse and blood pressure using a stethoscope become unreliable in the high noise. Cramped working conditions and bulky gear during air evacuation exacerbate these problems.
  • Most conventional methods use devices that employ electrodes, leads, wires, and cuffs to measure one or more vital signs, for example, blood pressure machine, ECG monitor, pulse oximeter. Existing monitors require some sort of attachment and thus are not passive. In addition, conventional equipment is highly sensitive to noise, such as a helicopter or airplane engines and rotors.
  • Clearly, what is needed for this common situation is a monitor that can consistently and accurately measure vital signs during a medical evacuation where there is high noise and vibration. The monitor being relatively autonomous intervention by a nurse or technician is not required. With the added capability of telemetry for remote monitoring and communication, information may be forwarded in real-time via wireless communication to the destination where medical personnel and other caregivers are located.
  • Needs exist to develop better methods and apparatus for physiological monitoring.
  • SUMMARY OF THE INVENTION
  • The present invention is known as Passive Physiological Monitoring, P2M, or simply P2M. Data records with vast information, such as blood pressure, are measured, recorded, and may later be delineated to determine the physical condition of the subject being monitored.
  • Recent developments in materials science and data processing have created the potential for a new monitoring device using piezoelectric film, an electrically active fluoropolymer. Although the medical applications of piezoelectric film are still at the infant stage, the testing of medical instruments is promising.
  • The cardiovascular system is modeled as a system of pipes, pumps, and other appendices, with the engineering phenomenon known as “water hammer” as the basis for a working model for data analysis in the calculation of blood pressure.
  • “Water hammer” is a compression wave transmitted through the household plumbing network of pipes and valves when household water is abruptly shut off. The result is a noticeable sound and the deterioration of the plumbing system. Water hammer is caused by the increase in pipe pressure caused by sudden velocity change, typically after water is shut off during a valve closing. The compression wave is described as follows:
  • c = 1 ρ * P V ( 1 )
  • where
  • c=speed of the compression wave (ft/sec);
  • dV=change in velocity (Vinitial−Vfinal);
  • ρ=density of the fluid; and
  • dP=change in pressure.
  • Skalak (1966) applied the linearized theory of viscous flow to develop a basis for understanding the main waveform features in arteries and veins. The vascular system is equivalent to a network of non-uniform transmission lines.
  • Womersly (1957) had applied those principles to a single uniform tube representing an arterial segment and compared the results to the experimental data taken in a dog, prior to Skalak's theory. Good agreement was reported between the measured flow and the flow computed from the measured pressure gradient.
  • Anliker (1968) showed that the dispersion phenomena associated with waves propagating in blood vessels are potential measures of the distubility of the vessels and other cardiac parameters. Anliker assumed that vessels behave like thin-walled cylindrical shells filled with inviscid compressible fluid. More complete models have provided good agreement.
  • Karr (1982) studied pressure wave velocity on human subjects and developed a method to determine the pulse propagation speed. The invention recognizes that such information may be used to determine plaque buildup, cholesterol concentration on the arterial wall, and arterial wall thickness.
  • Equation (1) allows for determination of pressure change (dP) from the heart pulsing based on the dispersion relationship between pulse wave velocity (c) and flow velocity (v). Karr's method measures flow velocity to determine dP, which is related to systolic pressure (pS) and diastolic pressure (pD).
  • The new invention measures the pressure energy from heartbeat and respiration collectively. The heart contribution to the energy spectrum is determined by removing the respiration contribution to the energy spectrum. Respiration energy is filtered out by comparing the energy spectrum calculations of velocity with velocity measures using electromagnetic and doppler methods. Since the sympathetic tone may influence blood pressure measurement accuracy, the new monitor can be configured for one of its piezoelectric sensors to serve as a dedicated doppler sensor that uses ultrasonics to adjust interpretations of data as a function of the sympathetic tone of the patient. The selective omission of P2M signals and the selective comparison of P2M sensor data with data from other parts of the body, as well as comparisons between two or more simultaneously triggered sensors, isolates energy contributions from the heart. P2M energy spectra determined from the foot differs from spectra derived from the chest area, which provides a means for isolating heart energy as the foot spectra is largely void of energy from respiration.
  • Once velocity (v) is known, the relation between systolic and diastolic blood pressure (2) and the Bernoulli equation (3) is used to measure blood pressure. The Bernoulli equation is a fundamental relationship in fluid mechanics that is derived from Newtonian mechanics and the principle of conservation of energy. A more compressive version of the same equation can be developed to reflect more complicated non-steady flows.
  • p = pD + 1 3 * ( pS + pD ) ( 2 )
  • where
  • pS=systolic pressure;
  • pD=diastolic pressure; and
  • p=average pressure.

  • p=ρgh+1/2*ρ*V 2   (3)
  • where
  • ρ=fluid density,
  • g=gravitational constant, and
  • h=height, head energy term.
  • From these equations we can develop expressions for pD and pS, both as a function of the pulse wave velocity (c), flow velocity (v) and pulse wave pressure (dP):

  • pD=1/2*ρ*v 2 −ρ*C*dV   (4)

  • pS=pD+ρ*C*dV   (5)
  • P2M is well-suited to assist medical personnel in several areas including, but not limited to, the following situations:
  • (1) Medical monitoring of vital signs of severely injured persons in high noise and vibration environments such as rescue helicopter where current monitoring techniques are cumbersome or impossible;
  • (2) Monitoring casualties resulting from major disasters such as aircraft accidents, earthquakes and floods;
  • (3) Physiological monitoring of large numbers of patients through a “smart stretcher” easily deployed for field use by medical personnel;
  • (4) Continuous military hospital bed monitoring without disturbing patients; and
  • (5) Patient monitoring when treatment is delayed due to temporary overload of medical facilities.
  • The development of the P2M or a passive sensor array (multi-sensor system) is a significant innovation in passive monitoring. Through the use of a grid of passive sensors, noise can be reduced through correlating signals from different pads to discern noise from biological signals. This is very important in high-noise environments. Additionally, the significance of a passive multi-sensor system is that it affords the opportunity to more comprehensively monitor a patient. As a tool, the grid of passive sensors provides an innovative way to monitor patients in adverse ambient conditions. The system provides a tool whereby parameters other than blood pressure, heart rate, and respiration can be measured. These parameters include, but are not limited to, patient movement and sleep habits, pulse strength over various portions of the body, relative blood flow volumes, and cardiac output, among others.
  • The main components of the Passive Physiological (P2M) system are the passive sensor, hardware for amplification, filtering, data-acquisition, and signal-analysis software. In a preferred embodiment, the single passive sensor has dimensions 8″×10″ and is preferably encased in a protective covering. Leads from the sensor attach to the electronics (amplifier, filter, data-acquisition card, desktop computer) where the raw analog voltage signal is filtered and amplified and converted to digital form. Digital filtering and software manipulation of the data in the form of frequency analyses are then performed. Finally, signal processing techniques are then used to extract physiological information from the digital signal.
  • The sensor pad is preferably placed directly beneath the back of a patient lying supine on a MEDEVAC litter. The mechanical/acoustic signals created by cardio-pulmonary function are transmitted through the body onto the passive sensor, which converts the signal into an analog voltage. An illustration of the existing P2M setup is shown in FIG. 6. Among the major hardware used for the laboratory setup are: desktop computer, a multi-function programmable charge amplifier and roll-around rack to encase all of the hardware. To maintain versatility for initial research and development, most of the equipment were chosen for functionality at the expense of space efficiency.
  • It is an object of the present invention to provide the military medical community with an inexpensive, non-restrictive, portable, light-weight, accurate, and reliable device that can be used in field or fixed facilities to provide an accurate measurement of heart rate, respiration and blood pressure in high noise and vibration environments and thus improve medical care in mass casualty situations, aeromedical evacuations and hospital settings.
  • It is an object of the present invention to adjust the signal noise to enable the use of piezoelectric instruments in aeromedical transport of patients, hospital bed monitoring, and other applications in the military and civilian medical environment.
  • It is an object of the present invention to develop a prototype physiological monitor using piezoelectric film in various field environments. The variables of accuracy, precision, user characteristics, and patient comfort determine the value of a field instrument for collection data on vital signs.
  • It is an object of the present invention to provide a non-invasive means for monitoring vital functions without the use of electrical leads or wiring on the patient. The use of the human body's acoustic and electromagnetic signals to determine heart rate, respirations, and blood pressure.
  • These and further and other objects and features of the invention are apparent in the disclosure, which includes the above and ongoing written specification, with the claims and the drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic of the P2M system components.
  • FIG. 2 is a perspective view of the P2M system.
  • FIG. 3 is a graphical comparison of the P2M bench test results and the human evaluator measurements.
  • FIG. 4 is a front view of the front panel display and user interface of the P2M system in Acquire Mode.
  • FIG. 5 is a front view of the front panel display of the P2M system in Monitor Mode.
  • FIG. 6 is a schematic view of a preferred embodiment of the P2M sensor.
  • FIG. 7 shows one of the graphical user interfaces (GUI) of the P2M system.
  • FIG. 8 shows the graphical user interface of the P2M system showing time-series and frequency-domain representations of physiological data.
  • FIG. 9 shows measurement of Pulse-Wave Travel Time (PWTT) FIG. 10 shows a system test and evaluation results in a graph.
  • FIG. 11 high noise and vibration testing of the P2M at Wheeler Army Air Field.
  • FIG. 12 shows the measurement through a body armor.
  • FIG. 13 shows testing through body armor and MOPP gear combined.
  • FIG. 14 shows a schematic view of the Passive Physiological Monitoring (P2M) System Using a passive sensor array and microelectronics incorporated into a MEDEVAC litter.
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • The preferred P2M system is a monitoring device with two major subsystems, one to measure signals and the other to process data into meaningful information.
  • FIG. 1 shows a schematic of the system, and FIG. 2 shows a perspective view of the system. First, the piezoelectric film, an electrically active fluoropolymer converts mechanical energy such as movement caused by a heartbeat into voltage measurements capable of supporting time series analysis techniques. Second, the voltage is recorded by and analyzed using a microcomputer controlled system, the purpose of which is to discriminate the signal from background noise and display it on a screen or printout. Techniques such as preamplifying and preconditioning through the use of high and low-band pass filters reduces noise.
  • The piezoelectric material 1 used is the polymer polyvinylidene fluoride (PVDF), which can be shaped into cables, thin film, or thick tiles. PVDF piezoelectric film is environmentally rugged, lightweight, flexible, inherently reliable, sturdy, easily repairable and transportable with excessive assembly or disassembly. Since the material is inert, it may be used inside the human body. Ultraviolet radiation passes harmlessly through the PVDF film, which may be produced in varying thicknesses. In addition, the piezoelectric film is waterproof, operates between 0 and 145 degrees Centigrade, and does not tear under stress. PVDF may convert a temperature reading into an electric output. The PVDF film is incorporated into a fluid-filled vinyl pad, approximately 10 cm by 10 cm in surface area. This is placed on/under/above various locations of the patient.
  • P2M detects cardiac and respiratory motion, and monitors pulse, respiration and apnea episodes 3. Cardiac and respiratory movements are simultaneously recorded by selective filtering of original signal. The piezoelectric element 1 is a pressure-sensing detector acting as a highly sensitive strain gage providing high dynamic range and linearity. Analog signals are fed through a band-pass filter into an amplifier (×200-×5000) 5 and are visually displayed. Analog acoustic signals are converted to digital values using a multi-channel converter 7 at a sampling rate of up to 5 kHz. Data is transformed to the frequency domain using Fast Fourier Transform (FFT). The system uses a microcomputer 9 for recording, analysis and presentation of data, which allows for on-line assessment of data and realtime decisions.
  • In its simplest mode of operation PVDF piezoelectric film 1 acts as a piezoelectric strain gage. The voltage output is up to four orders of magnitude higher than that produced by a nonamplified signal from circuitry used with resistive wire. Linearity and frequency response are excellent. Although similarities to a strain gage exist, current need not be applied since the device is electrically self-generating. Unlike the strain gage, the present invention does not produce an electric charge ad infinitum with sustained stress. The slowest frequency the polymer film detects is a thousand seconds for an electrical event to occur, and the highest is one gigahertz (microwave). The piezoelectric film is passive and biologically non-hazardous, as opposed to traditional strain gages that require an applied current.
  • PVDF sheets are commercial off-the-shelf (COTS) products, the type and specifications of which were chosen based on optimum sensitivity range and resilience. Each sheet contains seven-foot attached shielded twisted-pair (for noise rejection) leads 11 to transmit the charge produced by the sheets.
  • The piezoelectric sheets 1 are placed under a patient's chest and foot or at similarly remote areas of the body, or may be put on like a wrapped cuff. The change in pressure exerted by the patient's respiration and heartbeat causes the piezoelectric film to generate voltages, which is carried via nonmagnetic miniature coaxial cable 11 through a radio frequency filter 13. The signal is then directed to a high input-impedance amplifier 5 and computer system 7 for data processing. A conventional oscilloscope and a chart recorder displays the output. Respiration and heart rate 15 are then calculated by the energy spectrum from the time series data.
  • Several techniques reduce noise and vibration interferences. Active cancellation uses two piezoelectric sensors, one of which is not in contact with the body. The sensor not attached to the body is exposed to environmentally acoustic and vibrational signals, while the sensor attached to the body is exposed to environmental as well as body signals. Subtraction of one output from the other output yields the body signal of interest. Another preferred technique to reduce noise involves band-pass filtering/band-stop filtering. By identifying the extraneous electronic or acoustic noise and its particular frequencies, band-pass or band-stop filtering eliminates extraneous signals from the overall signal.
  • Additionally, signal processing techniques that use a prior knowledge of the expected signals extract the desired information from the piezoelectric signal. Spectral techniques help to identify the frequencies and amplitudes of the events of interest and discern them from extraneous noise.
  • Cardiac action analysis uses a bandpass frequency limit of 0.1-4.0 Hz, and respiration analysis uses a frequency limit from 0.01-3.0 Hz. The filtered cardiac and respiration signals are fed to a recording system. Body movements are analyzed by bandpass filtering the original signal with frequency limits from 0.1-20 Hz.
  • Once the signal produced by the film sensor is converted to voltages, amplified and filtered, it is processed through the P2M instrumentation. The hardware equipment includes, but is not limited to, a 586 processor computer 9 with enhanced RAM and disk capacity to handle large amounts of data. A board with a range that includes acoustic frequencies facilitates data acquisition, signal conditioning and signal processing.
  • For system operation, a master program 17 combines the three separate software modules of data acquisition/control, signal processing/analysis, and data display/user interface. The LabVIEW™ “G” graphical programming language was used for all three subroutine programs. The analog voltage signal is digitized and analyzed in time and frequency domains. Routines developed for signal conditioning and analysis include digital filtering, spectral analysis, auto correlation, and noise-rejection programs. The data is displayed real-time in either Monitor or Acquisition mode. Monitor mode displays the current data and discards old readings as new updates are processed, while Acquisition mode saves data for future analysis. The voluminous data must not exceed the disk-storage capacity of the computer in Acquisition mode.
  • For protection and ease of transport, the entire P2M system 19 is encased in a metal technical enclosure 21 with casters (not shown) and locking glass door (not shown), as shown in FIG. 2. The equipment also includes a MEDEVAC stretcher 23 on which the sensor is mounted. This device may be incorporated into a litter to eliminate the need for patient attachment or miniaturized as a portable field device in a purse with a wireless communication setup.
  • Significant field and analysis testing was conducted to confirm the workability and accuracy of the P2M system. The piezoelectric film measures mechanical, thermal and acoustic signals. That high sensitivity is necessary to measure vital signals non-intrusively. For pulse rate, the physical beating of the heart is transmitted through the body into the piezo-film sensor pad as mechanical impulses. The respiration is measured by the mechanical impulse transmitted to the sensor based on chest movements. The sensitive piezo-film sensor pad measures all extraneous movement and speech, resulting in a voltage signal output that is superimposed upon the physiological signals. As a result, movement or speech by the subject may cause a reading error.
  • The P2M sensor measures all physical impulses in the measuring environment, including the patient's physiological signals, nearby human noise and activity signals, noise and vibration from the machinery, and electromagnetic (EM) noise emitted from the lights and instrumentation. While the output signal includes all of these signals, many are too weak to affect the measurement while others such as EM noise corrupt the reading. Running the signal through filters and other signal-processing algorithms removes the noise. The conditioned signal is then analyzed through routines, including a fast Fourier transform (FFT) which identifies the primary signal frequencies. For a still, speechless patient, the primary frequency is usually respiration, and the second highest frequency is heart rate. Patient positioning and frequency harmonics may complicate the distinction, requiring additional logic to separate and identify the heart and respiration frequency peaks. The logic algorithms must be robust enough to define the respiration and heart peaks for a variety of conditions.
  • To increase resolution, a large number of high sampling rate data points were selected and re-sampled at a lower rate to simplify computation for accurate analysis. The minimum sampling interval was thirty seconds.
  • FIG. 3 shows the results for the twenty respiration/pulse-rate measurements performed with the P2M system. Human evaluator measurements were performed simultaneously as a control. P2M accurately measured pulse 25 and respiration 27 under ideal conditions, but patient movement or speech interfered with accurate measurement. Heart rate measurement quality was not reduced by the absence of respiration, and P2M matched the control measurement results 29, 31 with an error of less than beat per minute.
  • FIG. 4 shows the P2M front panel in Acquisition mode. The upper graph 33 displays a thirty-second window of time-series measurements of all physiological signals. Heartbeat spikes are shown in the upper (time series) graph 33, along with a lower-frequency sinusoidal function which corresponds to the respiration signal. The lower graph 35 shows the same data in the frequency domain. The first and largest spike 37 corresponds to approximately 16.4 respirations per minute. The control group 31 measured 17±2 respirations per minute. The large amplitude of the spike indicates that respiration is the largest impulse measured by the sensor pad. The second-largest spike 39 is sixty times per minute, which was identical to the actual heart rate measured by a fingertip-clip heart-rate monitor. The power as measured by the amplitude is less than one-third of that found in the respiration frequency, but the ratio varies based on the physiology and sensor pad positioning of the patient. The smaller spikes 41 in the lower graph represent respiration and heart-rate harmonics, a result of the harmonics not being a perfect sinusoidal function. Since the heart rate might fall at exactly the same frequency as a respiration harmonic, it is necessary for logic algorithms to check for harmonics. The heart rate and respiration harmonics may be differentiated by comparing signals taken from different parts of the body.
  • The buttons and menus 43 on the front panel of the interface program enables the control of data acquisition and analysis routines. The thirty-second data records may be saved to file for archiving or additional evaluation.
  • FIG. 5 shows the P2M system in Monitor mode. The top graph 45 shows the time-series data, with the characteristic higher-frequency heartbeat spikes 47 superimposed over a lower-frequency respiration wave 49. The middle graph 51 shows heart rate 53 and respiration 55 as updated every five seconds. As a new five-second data string is acquired, the oldest five seconds of data is discarded, and the heart rate and respiration are re-calculated by analyzing the thirty-second data string with the new data. The upper curve 53 is colored red to signify heart rate, while the lower curve 55 is colored blue to signify respiration. Heart rate appears steady in the mid-50s range, with respiration in the mid-teens. Both compare favorably (±2) with human control measurements. The anomaly 57 after 25 updates is attributable to patient movement or an extraneous and errant noise/vibration event. The bottom graph 59 shows an FFT of the time-series signal.
  • Regular voltage signals of heart beat provide strength signals as voltage levels that are related to blood pressure. Times between signals at varied parts of the body or patterns of secondary signals provide information on circulation or blockage or interference with blood flow.
  • In another preferred embodiment, FIG. 6 shows a schematic view of the P2M system with a single passive sensor 61 positioned on a patient 63. FIG. 7 shows one of the graphical user interfaces (GUI) of the P2M system. The upper chart 65 shows a 30-second window of digital voltage data, where the low-frequency oscillations are caused by respiration and the higher-frequency spikes are the result of heartbeat measurements of the patient on the litter. The time-series signal is converted to frequency data via a Fourier transform and displayed as a power spectrum, shown in the middle chart 67. From this data, pulse and respiration can be extracted by examining the power associated with the dominant frequencies 69.
  • In a preferred method of blood pressure measurement passive measurement of blood pressure (systolic and diastolic) may be conducted using pulse wave analyses. Measurement and characterization of the pulse-wave velocity (PWV), or alternately, the pulse-wave travel time (PWTT), inherently requires more than one measurement location. Thus, plural sensors are required for measurements in different locations. The sensors may measure pulse-wave characteristics, for example, along the brachial artery, along with other measurements described herein.
  • FIG. 8 shows measurement results of the pulse at two locations along the arm. The temporal separation between the two corresponding peaks 71, 73 gives the Pulse-Wave Travel Time (PWTT). This value can be used to correlate systolic and diastolic blood pressure. As such, the calibration must be performed simultaneously for several measurements of PWTT and blood pressure to construct a calibration curve. Barschdorff & Erig showed that the relationship between blood pressures (systolic and diastolic) are approximately linear with PWV and PWTT.
  • Testing and evaluation of the P2M system was performed at TAMC in February, 1998. Simultaneous measurements of pulse and respiration were performed with the P2M, an electronic monitor, and by human evaluation. FIG. 9 shows a photograph of the testing performed at TAMC. A total of 11 volunteers were monitored following the project's testing protocol.
  • FIG. 10 displays the results of the testing. The P2M was over 95% accurate as compared to conventional methods, and the several instances where the P2M was not in agreement with conventional methods proved to be very valuable in subsequent modifications and improvements to the system software. In addition, 12 volunteer nurses performed physiological monitoring of pulse and respiration using the P2M, electronic monitor, and human evaluation. Following the monitoring, the nurses completed a survey comparing and ranking the usage of the three methods.
  • Testing of the P2M system for pulse and respiration in a high noise and vibration environment was performed at Wheeler Army Air Field, on Mar. 5, 1999. Tests were performed during static display of a MEDEVAC helicopter. The main purpose of the test was to characterize the high noise/vibration environment using the P2M, microphones and accelerometers. Results showed that through filtering and signal analyses, the P2M was able to discern physiological signals from the high amplitude and frequency noise caused by the helicopter to output accurately pulse and respiration. No conventional methods were performed at this test due to the high-noise environment, which would render those methods useless.
  • FIG. 11 shows the high noise and vibration testing of P2M at Wheeler Army Air Field, on Mar. 5, 1999.
  • Next, in response to inquiries made by the flight medics during the Mar. 5, 1999 testing at Wheeler, the ability of P2M system to accurately monitor pulse and respiration through layers of clothing and gear was tested. Fragmentation protective body armor, Military Oriented Protective Posture (MOPP) gear, and a combination of the two were tested using the P2M system. Results showed that the P2M performed with higher fidelity with the additional layers between the subject and the sensor, which is largely due to the increased contact area and efficient transmission of mechanical and acoustic signals through the solid layers.
  • The single-sensor PN configuration that has been demonstrated to accurately measure pulse and respiration is very sensitive to the patient position relative to the main sensor pad. The quality and magnitude of the physiological signals received by the system depends on this positioning. The preferred optimum placement is to situate the sensor directly beneath the center of the patient's chest. If the sensor is moved from this placement, or if the patient position changes, the integrity of the incoming signal also changes. Thus, a preferred configuration uses multiple sensors in a pattern that covers the entire region of the litter on which the patient would lie so that regardless of patient movement and position, there will always be one or more active sensors in optimum measurement placements.
  • In a preferred embodiment, the invention is a passive system using an array of distributed sensors (or “multi-sensor”) capable of accurately and robustly monitoring certain physiological signals of the human body. These signals, in turn, may be processed for determination of vital signs that are currently used by nurses and other caregivers, for example, heart rate, respiration, and systolic/diastolic blood pressure.
  • Passive monitoring of such parameters as cardiac output, cardiac function, and internal bleeding are within the scope of this invention. The invention uniquely provides a device that is passive (completely non-invasive), unobtrusive, and autonomous; i.e., the apparatus in no way interferes either with the patient's mobility or with other monitoring equipment, and is capable of functioning with a minimum of technical expertise. In addition, the equipment functions reliably in high-noise environments and other situations that render alternative and existing methods ineffective. These environments include, but are not limited to, medical evacuation (MEDEVAC) by helicopter or ambulance, and operation through Military Oriented Protective Posture (MOPP) gear and body armor.
  • With the development of a reliable multi-sensor monitoring system for such rugged and noisy operation, the application to the hospital ICU environment, where noise is substantially lower, is considerably more straightforward. Completely non-invasive, passive, pulse, respiration, blood pressure (and detection of cardiac output, internal bleeding, shock, etc.) measurements using a sensor system that is undetectable to the patient have considerable intrinsic value even in noise-free surroundings. The passive and autonomous operation of such a system is suitable for telemetry and real-time remote monitoring, and the final feature of the invention is a telemetry design feature for distance and remote monitoring.
  • FIG. 14 shows a schematic of the P2M using a passive sensor array and microelectronics incorporated into a MEDEVAC litter. A schematic of the inventive technology, incorporated into a MEDEVAC litter, is shown in FIG. 14 below. The litter 75 is covered in an array 77 of 32 sensors, each of which can measure acoustic and hydraulic inputs from the patient 63. Each of these signals contains a measure of physiologically generated signal and environmental noise. The environmental noise on each pad will be similar, whereas the physiologically generated signals may be position dependent. This information is used to separate the signal from the noise using proven techniques. Position dependent physiological signals are used to determine patient position, heart rate, respiration, blood pressure, pulse strength distribution, and potentially some measure of cardiac output.
  • The invention may be incorporated into a wide range of applications apart from the MEDEVAC litter. The passive sensor array may be configured without much change to operate on a hospital bed or an ordinary mattress used at home. Of particular note is the area of premature infant care. In this case, the attachment of sensor leads to the infant may often be difficult, causing irritation of sensitive skin and entanglement in leads. The sensor may be incorporated into equipment for use in both civilian and military sectors. The sensor may be incorporated into field equipment, clothes and uniforms. This includes, but is not limited to, cervical collars, body armor, biological and/or chemical hazard protection suits, extraction devices, clothes, cushions on seats and seatbacks. Exercise equipment, such as stationary bicycles, treadmills or steppers may benefit by incorporating sensors into the supports.
  • Physiological indicators such as heart rate may be detected through handholds as an aid to regulating the exercise regime. Other useful applications might include the use of a passive sensor system in a chair or couch used for psychological examinations. Scrutiny of the subject's physiological signs may give indications of emotional disturbance caused by trigger words or events during counseling. The size of each sensor, number of sensors in the array, and configuration of the sensor array may be tailored, without much experimentation, to particular needs and situations. For a mattress, for example, 32 or more sensors in a rectangular array may be required.
  • The preferred passive sensor may use piezo-electric films and ceramics, hydrophones, microphones or pressure transducers. Amplification hardware may include signal amplification circuitry and hardware, e.g., charge amplifier. Data acquisition hardware and signal processing hardware (circuitry) and software are used in the system. For the interface between sensor and patient either solid, fluidized (air) or fluid layer may be used, as for example, gel, water, foam, rubber, plastic, etc. The interface facilitates transmittal of physiological signals.
  • The invention has great medical value for field monitoring, hospital monitoring, transport monitoring, and home/remote monitoring. For example, the invention may have application in every hospital for passive monitoring of patients. The invention being undetectable to the patient, which adds comfort to the monitoring process.
  • While the invention has been described with reference to specific embodiments, modifications and variations of the invention may be constructed without departing from the scope of the invention.

Claims (17)

1-46. (canceled)
47. Apparatus for passively monitoring the physiology of a patient, comprising:
at least two sensors, each sensor comprising a piezoelectric polymer film, at least one of said sensors being disposed for passively coupling with the patient through a solid or semi-solid interface to detect movements associated with both physiological signals from the patient and vibrations from an environment around the patient, and at least one of said sensors not being coupled with the patient and being disposed to detect movements associated with vibrations in the environment around the patient;
a bandpass filter coupled with each of the sensors for filtering out acoustic signals and isolating sub-acoustic signals associated with mechanical vibration and movement;
a processor for isolating the physiological signals from the environmental signals by subtracting the signals of the sensor not coupled with the patient from the signals of the sensor coupled with the patient to provide physiological data; and
a display communicating with the processor for displaying the physiological data.
48. The apparatus of claim 47, wherein the piezoelectric polymer film is a polyvinylidene fluoride (PVDF) film.
49. The apparatus of claim 47, wherein the physiological data is selected from the group consisting of heart rate, respiration rate, blood pressure, cardiac output, cardiac function, internal bleeding, patient movement, apnea, pulse strength, blood flow volume, temperature and combinations thereof.
50. The apparatus of claim 47, wherein the processor further performs spectral analysis for discerning the physiological signals from the environmental signals.
51. The apparatus of claim 47, wherein the piezoelectric polymer films are disposed on a patient support, and wherein the patient support is a hospital bed or home bed.
52. The apparatus of claim 47, wherein the piezoelectric films are disposed on a patient support, and wherein the patient support is litter or stretcher.
53. The apparatus of claim 47, wherein the processor calculates a spectrum from the signals and extracts information associated with heart rate and respiration rate of the patient by identifying peaks in the spectrum corresponding to the heart rate and respiration rate of the patient.
54. The apparatus of claim 47, wherein the processor calculates respiration and heart rate by the energy spectrum from time series data provided by the sensors.
55. The apparatus of claim 47, wherein the at least one sensor disposed for passively coupling with the patient comprises at least two sensors disposed to measure pulse wave characteristics at different locations on the patient's body; and
wherein the processor extracts blood pressure information by calculating the pulse wave velocity or pulse wave travel time based on the temporal separation between the signals received by the sensors.
56. The apparatus of claim 47, wherein the processor transforms the signals into frequency signals including heart rate and respiration harmonics, and differentiates the heart rate and respiration harmonics by comparing signals taken from different locations on the patient's body.
57. The apparatus of claim 47, wherein the at least one sensor disposed for passively coupling with the patient comprises at least two sensors, at least one of said two sensors being disposed to sense data from the patient's foot and another of said two sensors being disposed to sense data from the patient's chest area; and
wherein the processor isolates energy contributions from the patient's heart by comparing the sensed data from the patient's foot with the sensed data from the patient's chest area.
58. The apparatus of claim 47, wherein
the sensors are disposed at different locations on a patient support for sensing physiological data from the patient;
the processor processes the signals to extract position dependent physiological from the signals, and
wherein said position dependent physiological signals are used to determine patient position on the support.
59. The apparatus of claim 47, wherein the at least two sensors are disposed on a substrate selected from a group consisting of an item of clothing, a stretcher, a bed, a litter, a cervical collar, body armor, body protection gear, a uniform, an extraction device, exercise equipment, furniture, a cushion, a seat and a seatback.
60. The apparatus of claim 47, wherein a plurality of said sensors are disposed in an array for passively coupling with the patient through a solid or semi-solid interface to detect movements associated with both physiological signals from the patient and vibrations from an environment around the patient, and wherein
the processor removes noise from the physiological signals by correlating the signals from the plurality of sensors coupled with the patient.
61. A method for passively monitoring the physiology of a patient in a high noise and vibration environment, comprising:
coupling a first piezoelectric polymer film sensor with the patient at a location on the patient's body through a solid or semi-solid interface to detect movements associated with both physiological signals from the patient and vibrations from an environment around the patient;
disposing a second piezoelectric polymer film sensor not coupled with the patient for detecting movements associated with vibrations in the environment around the patient;
sensing movement associated with both physiological signals and environmental signals with the first sensor;
sensing movement associated with environmental signals with the second sensor;
bandpass filtering the sensor signals to filter out acoustic signals and isolate the sub-acoustic signals associated with mechanical vibration and movement;
isolating the physiological signals from the environmental signals by using a processor to subtract the second sensor signal from the first sensor signals; and
displaying the physiological data.
62. The method of claim 61, further comprising coupling a plurality of said first sensors with the patient at different locations on the patient's body to detect movements associated with both physiological signals from the patient and vibrations from an environment around the patient; and
removing noise from the physiological signals by correlating the signals from the plurality of first sensors.
US14/334,595 1999-09-14 2014-07-17 Passive physiological monitoring (p2m) system Abandoned US20140323884A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/334,595 US20140323884A1 (en) 1999-09-14 2014-07-17 Passive physiological monitoring (p2m) system
US14/960,246 US20160157734A1 (en) 1999-09-14 2015-12-04 Passive physiological monitoring (p2m) system

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US15367999P 1999-09-14 1999-09-14
US09/662,006 US6984207B1 (en) 1999-09-14 2000-09-14 Passive physiological monitoring (P2M) system
US11/165,735 US20060063982A1 (en) 1999-09-14 2005-06-24 Passive physiological monitoring (P2M) system
US12/753,096 US20110066004A1 (en) 1999-09-14 2010-04-01 Passive physiological monitoring (p2m) system
US13/294,779 US20120259179A1 (en) 1999-09-14 2011-11-11 Passive physiological monitoring (p2m) system
US14/334,595 US20140323884A1 (en) 1999-09-14 2014-07-17 Passive physiological monitoring (p2m) system

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/294,779 Continuation US20120259179A1 (en) 1999-09-14 2011-11-11 Passive physiological monitoring (p2m) system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/960,246 Continuation US20160157734A1 (en) 1999-09-14 2015-12-04 Passive physiological monitoring (p2m) system

Publications (1)

Publication Number Publication Date
US20140323884A1 true US20140323884A1 (en) 2014-10-30

Family

ID=35517760

Family Applications (6)

Application Number Title Priority Date Filing Date
US09/662,006 Expired - Fee Related US6984207B1 (en) 1999-09-14 2000-09-14 Passive physiological monitoring (P2M) system
US11/165,735 Abandoned US20060063982A1 (en) 1999-09-14 2005-06-24 Passive physiological monitoring (P2M) system
US12/753,096 Abandoned US20110066004A1 (en) 1999-09-14 2010-04-01 Passive physiological monitoring (p2m) system
US13/294,779 Abandoned US20120259179A1 (en) 1999-09-14 2011-11-11 Passive physiological monitoring (p2m) system
US14/334,595 Abandoned US20140323884A1 (en) 1999-09-14 2014-07-17 Passive physiological monitoring (p2m) system
US14/960,246 Abandoned US20160157734A1 (en) 1999-09-14 2015-12-04 Passive physiological monitoring (p2m) system

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US09/662,006 Expired - Fee Related US6984207B1 (en) 1999-09-14 2000-09-14 Passive physiological monitoring (P2M) system
US11/165,735 Abandoned US20060063982A1 (en) 1999-09-14 2005-06-24 Passive physiological monitoring (P2M) system
US12/753,096 Abandoned US20110066004A1 (en) 1999-09-14 2010-04-01 Passive physiological monitoring (p2m) system
US13/294,779 Abandoned US20120259179A1 (en) 1999-09-14 2011-11-11 Passive physiological monitoring (p2m) system

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/960,246 Abandoned US20160157734A1 (en) 1999-09-14 2015-12-04 Passive physiological monitoring (p2m) system

Country Status (1)

Country Link
US (6) US6984207B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10339911B2 (en) 2016-11-01 2019-07-02 Stryker Corporation Person support apparatuses with noise cancellation
US10842701B2 (en) 2016-10-14 2020-11-24 Stryker Corporation Patient support apparatus with stabilization

Families Citing this family (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984207B1 (en) * 1999-09-14 2006-01-10 Hoana Medical, Inc. Passive physiological monitoring (P2M) system
US7629890B2 (en) 2003-12-04 2009-12-08 Hoana Medical, Inc. System and methods for intelligent medical vigilance with bed exit detection
US7666151B2 (en) * 2002-11-20 2010-02-23 Hoana Medical, Inc. Devices and methods for passive patient monitoring
CA2397185A1 (en) * 2002-08-05 2004-02-05 Christian Cloutier Baby activity monitor
US7725150B2 (en) * 2003-06-04 2010-05-25 Lifewave, Inc. System and method for extracting physiological data using ultra-wideband radar and improved signal processing techniques
JP2007524468A (en) * 2003-06-26 2007-08-30 ホアナ メディカル、インコーポレイテッド Radiation stress type non-invasive blood pressure measurement method
US20050022606A1 (en) * 2003-07-31 2005-02-03 Partin Dale L. Method for monitoring respiration and heart rate using a fluid-filled bladder
US20060287590A1 (en) * 2003-09-18 2006-12-21 Mceowen Edwin L Noninvasive vital sign measurement device
US7559894B2 (en) * 2003-09-18 2009-07-14 New Paradigm Concepts, LLC Multiparameter whole blood monitor and method
US7396331B2 (en) * 2003-10-27 2008-07-08 Home Guardian, Llc System and process for non-invasive collection and analysis of physiological signals
AU2004296792B2 (en) 2003-12-04 2012-04-19 Hoana Medical, Inc. Intelligent medical vigilance system
US20070118054A1 (en) 2005-11-01 2007-05-24 Earlysense Ltd. Methods and systems for monitoring patients for clinical episodes
US8491492B2 (en) 2004-02-05 2013-07-23 Earlysense Ltd. Monitoring a condition of a subject
JP4809779B2 (en) 2004-02-05 2011-11-09 アーリーセンス・リミテッド Prediction and monitoring technology for clinical onset in respiration
US8403865B2 (en) 2004-02-05 2013-03-26 Earlysense Ltd. Prediction and monitoring of clinical episodes
US8942779B2 (en) 2004-02-05 2015-01-27 Early Sense Ltd. Monitoring a condition of a subject
CA2556894A1 (en) * 2004-02-18 2005-09-01 Hoana Medical, Inc. Method and system for integrating a passive sensor array with a mattress for patient monitoring
IL164991A0 (en) * 2004-06-10 2005-12-18 Nexense Ltd High-sensitivity sensors, sensor assemblies, and sensor apparatus for sensing various parameters
FI120961B (en) * 2004-07-01 2010-05-31 Emfit Oy Method and apparatus for measuring and monitoring vital signs or presence
US7882834B2 (en) 2004-08-06 2011-02-08 Fisher & Paykel Healthcare Limited Autotitrating method and apparatus
US7594891B2 (en) * 2005-12-29 2009-09-29 Moore Roy D Portable physiological parameter monitor
US8920343B2 (en) 2006-03-23 2014-12-30 Michael Edward Sabatino Apparatus for acquiring and processing of physiological auditory signals
IL176025A0 (en) * 2006-05-30 2007-08-19 Nexense Ltd Force or displacement sensor
WO2008024561A2 (en) * 2006-07-05 2008-02-28 Stryker Corporation A system for detecting and monitoring vital signs
US20100058480A1 (en) * 2006-07-13 2010-03-04 Sven-Erik Hedberg Information management in devices worn by a user
FR2905587B1 (en) * 2006-09-13 2009-02-27 Inst Nat Sante Rech Med DEVICE AND METHOD FOR TIME ANALYSIS OF AGITATION OF ALITE PATIENT.
US20100170043A1 (en) * 2009-01-06 2010-07-08 Bam Labs, Inc. Apparatus for monitoring vital signs
US20080077020A1 (en) * 2006-09-22 2008-03-27 Bam Labs, Inc. Method and apparatus for monitoring vital signs remotely
US8979755B2 (en) * 2006-12-08 2015-03-17 The Boeing Company Devices and systems for remote physiological monitoring
WO2008085157A1 (en) * 2007-01-08 2008-07-17 Juvent Inc. Non-invasive blood flow monitor
JP4896763B2 (en) * 2007-02-19 2012-03-14 株式会社東芝 Respiratory suppression member and magnetic resonance imaging apparatus
US20090118593A1 (en) * 2007-11-07 2009-05-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Determining a demographic characteristic based on computational user-health testing of a user interaction with advertiser-specified content
US20090119154A1 (en) * 2007-11-07 2009-05-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Determining a demographic characteristic based on computational user-health testing of a user interaction with advertiser-specified content
US20080242949A1 (en) * 2007-03-30 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational user-health testing
US20080242947A1 (en) * 2007-03-30 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Configuring software for effective health monitoring or the like
US20080243543A1 (en) * 2007-03-30 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Effective response protocols for health monitoring or the like
US20090024050A1 (en) * 2007-03-30 2009-01-22 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational user-health testing
US20080243005A1 (en) * 2007-03-30 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational user-health testing
US20090018407A1 (en) * 2007-03-30 2009-01-15 Searete Llc, A Limited Corporation Of The State Of Delaware Computational user-health testing
US20090005653A1 (en) * 2007-03-30 2009-01-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational user-health testing
US20080319276A1 (en) * 2007-03-30 2008-12-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational user-health testing
US20090005654A1 (en) * 2007-03-30 2009-01-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational user-health testing
US20080242951A1 (en) * 2007-03-30 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Effective low-profile health monitoring or the like
US20080242952A1 (en) * 2007-03-30 2008-10-02 Searete Llc, A Limited Liablity Corporation Of The State Of Delaware Effective response protocols for health monitoring or the like
US20080242948A1 (en) * 2007-03-30 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Effective low-profile health monitoring or the like
US8585607B2 (en) 2007-05-02 2013-11-19 Earlysense Ltd. Monitoring, predicting and treating clinical episodes
EP2142095A1 (en) * 2007-05-02 2010-01-13 Earlysense Ltd. Monitoring, predicting and treating clinical episodes
WO2008148040A1 (en) * 2007-05-24 2008-12-04 Lifewave, Inc. System and method for non-invasive instantaneous and continuous measurement of cardiac chamber volume
US8199000B2 (en) * 2007-09-27 2012-06-12 General Electric Company System and method for interference mitigation in a wireless sensor network
US20090292212A1 (en) * 2008-05-20 2009-11-26 Searete Llc, A Limited Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US8636670B2 (en) 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US20090287120A1 (en) * 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090287109A1 (en) * 2008-05-14 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090287191A1 (en) * 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090287101A1 (en) * 2008-05-13 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US20090287094A1 (en) * 2008-05-15 2009-11-19 Seacrete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US8372018B2 (en) 2008-01-16 2013-02-12 International Business Machines Corporation Support device and palpation device and methods of use
US20090192364A1 (en) * 2008-01-29 2009-07-30 Voto Andrew M Infant monitoring system
US20090240160A1 (en) * 2008-03-19 2009-09-24 Thompson Loren M Infant monitoring system
US20100152600A1 (en) * 2008-04-03 2010-06-17 Kai Sensors, Inc. Non-contact physiologic motion sensors and methods for use
CA2720871A1 (en) * 2008-04-03 2009-10-08 Kai Medical, Inc. Non-contact physiologic motion sensors and methods for use
US9883809B2 (en) 2008-05-01 2018-02-06 Earlysense Ltd. Monitoring, predicting and treating clinical episodes
US8882684B2 (en) 2008-05-12 2014-11-11 Earlysense Ltd. Monitoring, predicting and treating clinical episodes
JP2012502671A (en) 2008-05-12 2012-02-02 アーリーセンス エルティディ Monitoring, prediction and treatment of clinical symptoms
US20090312612A1 (en) * 2008-06-17 2009-12-17 The General Electric Company Method, system and apparatus for monitoring patients
US20090318773A1 (en) * 2008-06-24 2009-12-24 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Involuntary-response-dependent consequences
WO2010006265A2 (en) * 2008-07-10 2010-01-14 Texas Heart Institute Method and system for temperature analysis to provide an early marker of congestive heart failure progress that precedes a patient's symptoms
US8301219B2 (en) * 2008-07-16 2012-10-30 The General Hospital Corporation Patient monitoring systems and methods
US8281433B2 (en) * 2008-10-24 2012-10-09 Hill-Rom Services, Inc. Apparatuses for supporting and monitoring a person
US8444558B2 (en) * 2009-01-07 2013-05-21 Bam Labs, Inc. Apparatus for monitoring vital signs having fluid bladder beneath padding
US8287452B2 (en) * 2009-01-07 2012-10-16 Bam Labs, Inc. Apparatus for monitoring vital signs of an emergency victim
US9002427B2 (en) * 2009-03-30 2015-04-07 Lifewave Biomedical, Inc. Apparatus and method for continuous noninvasive measurement of respiratory function and events
US20100256505A1 (en) * 2009-04-03 2010-10-07 Jingping Xu Health monitoring method and system
WO2010124117A2 (en) 2009-04-22 2010-10-28 Lifewave, Inc. Fetal monitoring device and methods
CN101545819B (en) * 2009-05-05 2010-08-18 西北工业大学 Method of calibrating PVDF voltage coefficient when measuring gauge pressure of rotary body
US8103338B2 (en) 2009-05-08 2012-01-24 Rhythmia Medical, Inc. Impedance based anatomy generation
US8571647B2 (en) 2009-05-08 2013-10-29 Rhythmia Medical, Inc. Impedance based anatomy generation
US20110301432A1 (en) 2010-06-07 2011-12-08 Riley Carl W Apparatus for supporting and monitoring a person
US8525679B2 (en) 2009-09-18 2013-09-03 Hill-Rom Services, Inc. Sensor control for apparatuses for supporting and monitoring a person
US8852114B2 (en) * 2009-12-22 2014-10-07 Stichting Imec Nederland Heart pulse rate monitor
US8844073B2 (en) 2010-06-07 2014-09-30 Hill-Rom Services, Inc. Apparatus for supporting and monitoring a person
US8672853B2 (en) 2010-06-15 2014-03-18 Bam Labs, Inc. Pressure sensor for monitoring a subject and pressure sensor with inflatable bladder
US8672842B2 (en) 2010-08-24 2014-03-18 Evacusled Inc. Smart mattress
US20120053423A1 (en) * 2010-08-24 2012-03-01 Christopher Kenalty Smart mattress
US8712724B2 (en) 2010-09-30 2014-04-29 Fitbit, Inc. Calendar integration methods and systems for presentation of events having combined activity and location information
US8738323B2 (en) 2010-09-30 2014-05-27 Fitbit, Inc. Methods and systems for metrics analysis and interactive rendering, including events having combined activity and location information
US8954290B2 (en) 2010-09-30 2015-02-10 Fitbit, Inc. Motion-activated display of messages on an activity monitoring device
US11243093B2 (en) 2010-09-30 2022-02-08 Fitbit, Inc. Methods, systems and devices for generating real-time activity data updates to display devices
US8954291B2 (en) 2010-09-30 2015-02-10 Fitbit, Inc. Alarm setting and interfacing with gesture contact interfacing controls
US8620617B2 (en) 2010-09-30 2013-12-31 Fitbit, Inc. Methods and systems for interactive goal setting and recommender using events having combined activity and location information
US10983945B2 (en) 2010-09-30 2021-04-20 Fitbit, Inc. Method of data synthesis
US8738321B2 (en) 2010-09-30 2014-05-27 Fitbit, Inc. Methods and systems for classification of geographic locations for tracked activity
US8762102B2 (en) 2010-09-30 2014-06-24 Fitbit, Inc. Methods and systems for generation and rendering interactive events having combined activity and location information
US9390427B2 (en) 2010-09-30 2016-07-12 Fitbit, Inc. Methods, systems and devices for automatic linking of activity tracking devices to user devices
US8805646B2 (en) 2010-09-30 2014-08-12 Fitbit, Inc. Methods, systems and devices for linking user devices to activity tracking devices
US10004406B2 (en) 2010-09-30 2018-06-26 Fitbit, Inc. Portable monitoring devices for processing applications and processing analysis of physiological conditions of a user associated with the portable monitoring device
US8744803B2 (en) 2010-09-30 2014-06-03 Fitbit, Inc. Methods, systems and devices for activity tracking device data synchronization with computing devices
US8615377B1 (en) 2010-09-30 2013-12-24 Fitbit, Inc. Methods and systems for processing social interactive data and sharing of tracked activity associated with locations
US9167991B2 (en) 2010-09-30 2015-10-27 Fitbit, Inc. Portable monitoring devices and methods of operating same
US9148483B1 (en) 2010-09-30 2015-09-29 Fitbit, Inc. Tracking user physical activity with multiple devices
US8762101B2 (en) 2010-09-30 2014-06-24 Fitbit, Inc. Methods and systems for identification of event data having combined activity and location information of portable monitoring devices
US9241635B2 (en) 2010-09-30 2016-01-26 Fitbit, Inc. Portable monitoring devices for processing applications and processing analysis of physiological conditions of a user associated with the portable monitoring device
US8694282B2 (en) 2010-09-30 2014-04-08 Fitbit, Inc. Methods and systems for geo-location optimized tracking and updating for events having combined activity and location information
US10292625B2 (en) 2010-12-07 2019-05-21 Earlysense Ltd. Monitoring a sleeping subject
US8991392B1 (en) 2010-12-21 2015-03-31 Fisher & Paykel Healthcare Limited Pressure adjustment method for CPAP machine
CN102579020A (en) * 2011-01-05 2012-07-18 深圳市迈迪加科技发展有限公司 Respiration and heartbeat monitoring system based on piezoelectric cable sensor
US9626650B2 (en) 2011-04-14 2017-04-18 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US10445846B2 (en) 2011-04-14 2019-10-15 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US9861550B2 (en) 2012-05-22 2018-01-09 Hill-Rom Services, Inc. Adverse condition detection, assessment, and response systems, methods and devices
EP2666406A3 (en) 2012-05-22 2013-12-04 Hill-Rom Services, Inc. Occupant egress prediction systems, methods and devices
US9641239B2 (en) 2012-06-22 2017-05-02 Fitbit, Inc. Adaptive data transfer using bluetooth
US10292605B2 (en) 2012-11-15 2019-05-21 Hill-Rom Services, Inc. Bed load cell based physiological sensing systems and methods
US9728059B2 (en) 2013-01-15 2017-08-08 Fitbit, Inc. Sedentary period detection utilizing a wearable electronic device
US9333136B2 (en) 2013-02-28 2016-05-10 Hill-Rom Services, Inc. Sensors in a mattress cover
JP6240751B2 (en) 2013-05-06 2017-11-29 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Anatomic mapping system for continuous display of recent heart rate characteristics during real-time or playback electrophysiological data visualization
US9918649B2 (en) 2013-05-14 2018-03-20 Boston Scientific Scimed Inc. Representation and identification of activity patterns during electro-physiology mapping using vector fields
CZ308222B6 (en) * 2013-10-08 2020-03-11 Linet Spol. S. R. O. Device for contactless monitoring of vital patient signs
US10751001B2 (en) * 2013-12-03 2020-08-25 General Electric Company Systems and methods for tracking and analysis of electrical-physiological interference
US20150254419A1 (en) * 2014-03-06 2015-09-10 Boston Scientific Scimed, Inc. Medical devices for mapping cardiac tissue and methods for displaying mapping data
US10610113B2 (en) 2014-03-31 2020-04-07 The Regents Of The University Of Michigan Miniature piezoelectric cardiovascular monitoring system
CN104000567B (en) * 2014-06-13 2017-01-11 河海大学常州校区 Portable multipoint pulse wireless monitoring system
US10521558B2 (en) 2014-06-27 2019-12-31 Coherence Apps, Llc Systems and methods for delivering remedy frequencies
US9572507B2 (en) 2014-09-10 2017-02-21 Dymedix Corporation Combination physiologic sensor
US11284808B2 (en) 2014-10-11 2022-03-29 Linet Spol. S.R.O. Device and method for measurement of vital functions, including intracranial pressure, and system and method for collecting data
JP6385789B2 (en) 2014-10-21 2018-09-05 日本光電工業株式会社 Biological information measuring device, biological information display method, and program
US9721141B2 (en) * 2014-10-30 2017-08-01 Polar Electro Oy Wrist-worn apparatus control with fingerprint data
WO2016081519A1 (en) * 2014-11-17 2016-05-26 Borkholder David A Blood pressure and arterial compliance estimation from arterial segments
CN105012085A (en) * 2015-07-14 2015-11-04 苏克莉 Multifunctional transport frame for cardiovascular department
US10405766B2 (en) 2015-09-26 2019-09-10 Boston Scientific Scimed, Inc. Method of exploring or mapping internal cardiac structures
EP3353753A1 (en) 2015-09-26 2018-08-01 Boston Scientific Scimed Inc. Systems and methods for anatomical shell editing
EP3352648B1 (en) 2015-09-26 2022-10-26 Boston Scientific Scimed Inc. Multiple rhythm template monitoring
EP3474733A1 (en) 2016-06-22 2019-05-01 Linet Spol. S.R.O. Medical data collection system and method of use thereof
US11330995B2 (en) * 2016-06-28 2022-05-17 Softcare Co., Ltd. Apparatus and method for imaging and analyzing hemodynamics
US20190223764A1 (en) 2016-10-14 2019-07-25 Blink Device LLC Quantitative neuromusculature blockade sensing systems and methods
WO2018126182A1 (en) 2016-12-31 2018-07-05 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
US11172892B2 (en) 2017-01-04 2021-11-16 Hill-Rom Services, Inc. Patient support apparatus having vital signs monitoring and alerting
DE102017100573A1 (en) 2017-01-13 2018-07-19 Schaeffler Technologies AG & Co. KG Detector arrangement for the selective detection of vibrations on components
WO2019000337A1 (en) * 2017-06-29 2019-01-03 深圳和而泰智能家居科技有限公司 Physiological information measuring method, storage medium, physiological information monitoring device and equipment
CN114983981A (en) 2018-06-27 2022-09-02 比奥克斯塞尔医疗股份有限公司 Dexmedetomidine-containing film preparation and method for producing the same
US10631734B1 (en) * 2018-12-27 2020-04-28 Endra Life Sciences Inc. Method and system for monitoring tissue temperature
US11540760B1 (en) 2019-05-03 2023-01-03 Enceinte Health, Inc. Retrofittable and portable commode and systems for detecting, tracking, and alerting health changes
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CN110477887A (en) * 2019-09-18 2019-11-22 浙江理工大学 A kind of monitoring device of non-invasive long-range apnea syndrome
CN110766913A (en) * 2019-11-22 2020-02-07 上海工程技术大学 Fatigue driving monitoring system based on PVDF piezoelectric film sensor
CN114287885B (en) * 2021-12-28 2023-12-08 深圳数联天下智能科技有限公司 Human body sign monitoring method, device, system and storage medium
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954100A (en) * 1974-12-10 1976-05-04 International Defense Consultant Services, Inc. Flexible sensor pad for non-attached monitoring EKG signals of human subjects
US4633237A (en) * 1984-07-11 1986-12-30 Kenneth A. Tucknott Patient bed alarm system
US4686999A (en) * 1985-04-10 1987-08-18 Tri Fund Research Corporation Multi-channel ventilation monitor and method
US4862361A (en) * 1985-06-05 1989-08-29 Massachusetts Institute Of Technology Methods and apparatus for monitoring cardiovascular regulation using heart rate power spectral analysis
US4862144A (en) * 1987-04-21 1989-08-29 Tao Billy S K Movement monitor
US5309916A (en) * 1990-07-18 1994-05-10 Avl Medical Instruments Ag Blood pressure measuring device and method
WO1996015713A1 (en) * 1994-11-24 1996-05-30 The Institute Of Respiratory Medicine Limited Biophysical foetus monitor
US5989193A (en) * 1995-05-19 1999-11-23 Somed Pty Limited Device and method for detecting and recording snoring
US6050950A (en) * 1996-12-18 2000-04-18 Aurora Holdings, Llc Passive/non-invasive systemic and pulmonary blood pressure measurement
US6547743B2 (en) * 1997-05-16 2003-04-15 Resmed Limited Respiratory-analysis systems

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742937A (en) * 1971-01-20 1973-07-03 B Manuel Cardiac monitor
US3898981A (en) * 1971-09-01 1975-08-12 Electronic Monitors Inc Respiration monitoring apparatus
US4033332A (en) 1972-09-11 1977-07-05 Cavitron Corporation Activity and respiration monitor
US3926177A (en) 1972-09-11 1975-12-16 Cavitron Corp Activity and respiration monitor
US3996922A (en) 1973-08-17 1976-12-14 Electronic Monitors, Inc. Flexible force responsive transducer
US4403215A (en) 1977-12-27 1983-09-06 Hellige, Gmbh Apparatus for automatically monitoring body functions
US4245648A (en) * 1978-09-20 1981-01-20 Trimmer Gordon A Method and apparatus for measuring blood pressure and pulse rate
US4320766A (en) 1979-03-13 1982-03-23 Instrumentarium Oy Apparatus in medicine for the monitoring and or recording of the body movements of a person on a bed, for instance of a patient
FR2475804A1 (en) 1980-02-12 1981-08-14 Lewiner Jacques IMPROVEMENTS ON COMPOSITE SHEETS CONSTITUTING ELECTROMECHANICAL TRANSDUCERS AND TRANSDUCERS EQUIPPED WITH SUCH SHEETS
CH644260A5 (en) 1980-02-18 1984-07-31 Asulab Ag BLOOD PRESSURE MEASURING DEVICE.
CH642835A5 (en) 1980-02-18 1984-05-15 Asulab Ag BLOOD PRESSURE MEASURING DEVICE.
US4428380A (en) * 1980-09-11 1984-01-31 Hughes Aircraft Company Method and improved apparatus for analyzing activity
US4381788A (en) 1981-02-27 1983-05-03 Douglas David W Method and apparatus for detecting apnea
US4494553A (en) 1981-04-01 1985-01-22 F. William Carr Vital signs monitor
DE3116387C2 (en) 1981-04-24 1983-11-10 Asulab AG, 2502 Bienne Method of measuring a person's blood pressure and blood pressure measuring device
US4438771A (en) 1982-04-26 1984-03-27 University Of Virginia Alumni Patents Foundation Passive contactless monitor for detecting cessation of cardiopulmonary
US4474185A (en) 1982-05-12 1984-10-02 Diamond Donald A Body movement detector
US4510944A (en) * 1982-12-30 1985-04-16 Porges Stephen W Method and apparatus for evaluating rhythmic oscillations in aperiodic physiological response systems
US4446869A (en) 1983-03-07 1984-05-08 Trimed, Inc. Water absorbing trap to protect an infrared exhaled carbon dioxide apnea monitor of a patient's respiration
US4509527A (en) 1983-04-08 1985-04-09 Timex Medical Products Corporation Cardio-respiration transducer
US4537200A (en) * 1983-07-07 1985-08-27 The Board Of Trustees Of The Leland Stanford Junior University ECG enhancement by adaptive cancellation of electrosurgical interference
US4513748A (en) 1983-08-30 1985-04-30 Rca Corporation Dual frequency heart rate monitor utilizing doppler radar
GB2156985B (en) * 1984-04-02 1987-06-24 Teltec Electronic Equip Apparatus for measuring movable part-structures, eg blood vessels, within a living body
US4562723A (en) * 1984-07-27 1986-01-07 Hubner Hans J Method of and apparatus for the measurement of subterranean atmospheric parameters
GB2166871A (en) * 1984-09-03 1986-05-14 Vickers Plc Respiration monitor
US4595016A (en) 1985-01-30 1986-06-17 Mine Safety Appliances Co. APNEA monitor
US4926866A (en) * 1985-10-11 1990-05-22 Lee Arnold St J System for gathering physiological data
US4757825A (en) 1985-10-31 1988-07-19 Diamond Research Group, Inc. Cardio-pulmonary activity monitor
US4827763A (en) * 1986-04-11 1989-05-09 Purdue Research Foundation Pressure mapping system with capacitive measuring pad
US4734044A (en) * 1986-04-18 1988-03-29 Radice Peter F Connectors for use with piezoelectric polymeric film transducers
US4657026A (en) 1986-07-14 1987-04-14 Tagg James R Apnea alarm systems
US6375621B1 (en) 1987-03-06 2002-04-23 Ocean Laboratories, Inc. Passive apnea monitor
US4773422A (en) * 1987-04-30 1988-09-27 Nonin Medical, Inc. Single channel pulse oximeter
US4889131A (en) 1987-12-03 1989-12-26 American Health Products, Inc. Portable belt monitor of physiological functions and sensors therefor
IL86759A (en) 1988-06-16 1992-09-06 Dror Nedivi Medical monitoring system
US5036859A (en) * 1988-07-26 1991-08-06 Travis International, Inc. Moisture detector and indicator
US4989611A (en) * 1988-08-19 1991-02-05 Seismed Instruments, Inc. Cardiac compression wave measuring system and method
US5012815A (en) * 1989-02-02 1991-05-07 Yale University Dynamic spectral phonocardiograph
US4967760A (en) * 1989-02-02 1990-11-06 Bennett Jr William R Dynamic spectral phonocardiograph
US5448996A (en) 1990-02-02 1995-09-12 Lifesigns, Inc. Patient monitor sheets
SE465551B (en) * 1990-02-16 1991-09-30 Aake Oeberg DEVICE FOR DETERMINING A HEART AND RESPIRATORY FREQUENCY THROUGH PHOTOPLETISMOGRAPHICAL SEATING
US5235989A (en) * 1990-03-07 1993-08-17 Sleep Disorders Center Apparatus for sensing respiration movements
DE69128225T2 (en) * 1990-03-09 1998-03-19 Matsushita Electric Ind Co Ltd DEVICE FOR INDICATING SLEEP
US5241964A (en) * 1990-10-31 1993-09-07 Medwave, Incorporated Noninvasive, non-occlusive method and apparatus which provides a continuous indication of arterial pressure and a beat-by-beat characterization of the arterial system
US5490516A (en) * 1990-12-14 1996-02-13 Hutson; William H. Method and system to enhance medical signals for real-time analysis and high-resolution display
GB2252827A (en) 1991-02-12 1992-08-19 Josef Petr Prokopius Breathing detector
US5148002A (en) 1991-03-14 1992-09-15 Kuo David D Multi-functional garment system
US5144284A (en) * 1991-05-22 1992-09-01 Hammett Rawlings H Patient-monitoring bed covering device
US5137033A (en) * 1991-07-15 1992-08-11 Norton John L Patient monitoring device
US5544651A (en) 1992-09-08 1996-08-13 Wilk; Peter J. Medical system and associated method for automatic treatment
FI94589C (en) * 1992-09-15 1995-10-10 Increa Oy Method and apparatus for measuring physical fitness
US5292340A (en) * 1993-01-04 1994-03-08 Telectronics Pacing Systems, Inc. Physiologically-calibrated rate adaptive, dual chamber pacemaker
US5479932A (en) * 1993-08-16 1996-01-02 Higgins; Joseph Infant health monitoring system
US5724025A (en) * 1993-10-21 1998-03-03 Tavori; Itzchak Portable vital signs monitor
US5590649A (en) * 1994-04-15 1997-01-07 Vital Insite, Inc. Apparatus and method for measuring an induced perturbation to determine blood pressure
US5684460A (en) * 1994-04-22 1997-11-04 The United States Of America As Represented By The Secretary Of The Army Motion and sound monitor and stimulator
US5515865A (en) * 1994-04-22 1996-05-14 The United States Of America As Represented By The Secretary Of The Army Sudden Infant Death Syndrome (SIDS) monitor and stimulator
US5807267A (en) * 1994-06-01 1998-09-15 Advanced Body Metrics Corporation Heart pulse monitor
US5590650A (en) * 1994-11-16 1997-01-07 Raven, Inc. Non-invasive medical monitor system
AU710983B2 (en) * 1996-02-15 1999-10-07 Armand P. Neukermans Improved biocompatible transducers
US5853005A (en) * 1996-05-02 1998-12-29 The United States Of America As Represented By The Secretary Of The Army Acoustic monitoring system
US5913826A (en) * 1996-06-12 1999-06-22 K-One Technologies Wideband external pulse cardiac monitor
US6050940A (en) * 1996-06-17 2000-04-18 Cybernet Systems Corporation General-purpose medical instrumentation
FI101191B1 (en) 1996-06-20 1998-05-15 Polar Electro Oy Method and apparatus for detecting heart rate
CN1203805C (en) * 1996-09-10 2005-06-01 精工爱普生株式会社 Organism state measuring device and relaxation instructing device
US5808552A (en) * 1996-11-25 1998-09-15 Hill-Rom, Inc. Patient detection system for a patient-support device
IL119721A (en) * 1996-11-29 2005-08-31 Mindlife Ltd Method and system for monitoring the physiological condition of a patient
US6198394B1 (en) 1996-12-05 2001-03-06 Stephen C. Jacobsen System for remote monitoring of personnel
US6047203A (en) * 1997-03-17 2000-04-04 Nims, Inc. Physiologic signs feedback system
US5942979A (en) * 1997-04-07 1999-08-24 Luppino; Richard On guard vehicle safety warning system
FI103758B1 (en) 1997-09-12 1999-09-30 Polar Electro Oy Method and arrangement for measuring blood pressure
US6014346A (en) * 1998-02-12 2000-01-11 Accucure, L.L.C. Medical timer/monitor and method of monitoring patient status
US6017313A (en) 1998-03-20 2000-01-25 Hypertension Diagnostics, Inc. Apparatus and method for blood pressure pulse waveform contour analysis
US6224548B1 (en) 1998-05-26 2001-05-01 Ineedmd.Com, Inc. Tele-diagnostic device
US6248064B1 (en) 1998-05-26 2001-06-19 Ineedmd.Com,Inc. Tele-diagnostic device
US6280392B1 (en) * 1998-07-29 2001-08-28 Denso Corporation Infant condition monitoring system and method using load cell sensor sheet
US6146332A (en) * 1998-07-29 2000-11-14 3416704 Canada Inc. Movement detector
US6261237B1 (en) 1998-08-20 2001-07-17 Medacoustics, Inc. Thin film piezoelectric polymer sensor
AU746688B2 (en) 1998-09-02 2002-05-02 Med-Dev Limited Method and apparatus for subject monitoring
AU1198100A (en) 1998-09-23 2000-04-10 Keith Bridger Physiological sensing device
SE9803344L (en) 1998-10-01 2000-04-02 Biosys Ab Method and apparatus for monitoring a seated person
WO2000044580A1 (en) * 1999-01-27 2000-08-03 Compumedics Sleep Pty. Ltd. Vigilance monitoring system
US6494829B1 (en) 1999-04-15 2002-12-17 Nexan Limited Physiological sensor array
US6565515B2 (en) 1999-05-06 2003-05-20 Colin Corporation Pulse-wave-propagation-velocity-relating-information obtaining apparatus and blood-pressure-index measuring apparatus
JP4571317B2 (en) 1999-06-01 2010-10-27 マサチューセッツ インスティテュート オブ テクノロジー Pressureless continuous blood pressure monitoring device
DE19929328A1 (en) 1999-06-26 2001-01-04 Daimlerchrysler Aerospace Ag Device for long-term medical monitoring of people
JP3820811B2 (en) * 1999-08-02 2006-09-13 株式会社デンソー Respiratory system disease monitoring device
US6984207B1 (en) * 1999-09-14 2006-01-10 Hoana Medical, Inc. Passive physiological monitoring (P2M) system
US6415033B1 (en) 1999-09-15 2002-07-02 Ilife Systems, Inc. Physiological condition monitors utilizing very low frequency acoustic signals
ATE339154T1 (en) 1999-09-21 2006-10-15 Honeywell Hommed Llc HOME PATIENT MONITORING SYSTEM
US6440082B1 (en) 1999-09-30 2002-08-27 Medtronic Physio-Control Manufacturing Corp. Method and apparatus for using heart sounds to determine the presence of a pulse
JP3683448B2 (en) 1999-10-20 2005-08-17 松下電器産業株式会社 Physical parameter measurement device using vibration
US6600949B1 (en) 1999-11-10 2003-07-29 Pacesetter, Inc. Method for monitoring heart failure via respiratory patterns
US6497658B2 (en) 1999-12-19 2002-12-24 Michael F. Roizen Alarm upon detection of impending sleep state
AU2001221391A1 (en) 2000-01-26 2001-08-07 Vsm Medtech Ltd. Continuous blood pressure monitoring method and apparatus
US6575916B2 (en) 2000-03-24 2003-06-10 Ilife Solutions, Inc. Apparatus and method for detecting very low frequency acoustic signals
US6475153B1 (en) 2000-05-10 2002-11-05 Motorola Inc. Method for obtaining blood pressure data from optical sensor
JP4318062B2 (en) 2000-05-16 2009-08-19 日本光電工業株式会社 Biological signal monitor
EP1404213B1 (en) * 2000-05-19 2011-03-23 Welch Allyn Protocol Inc Patient monitoring system
US6485441B2 (en) 2000-07-14 2002-11-26 The Board Of Trustees Of The Leland Stanford Junior University SensorBed
US6821254B2 (en) * 2000-07-21 2004-11-23 Institute Of Critical Care Medicine Cardiac/respiratory arrest detector

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954100A (en) * 1974-12-10 1976-05-04 International Defense Consultant Services, Inc. Flexible sensor pad for non-attached monitoring EKG signals of human subjects
US4633237A (en) * 1984-07-11 1986-12-30 Kenneth A. Tucknott Patient bed alarm system
US4686999A (en) * 1985-04-10 1987-08-18 Tri Fund Research Corporation Multi-channel ventilation monitor and method
US4862361A (en) * 1985-06-05 1989-08-29 Massachusetts Institute Of Technology Methods and apparatus for monitoring cardiovascular regulation using heart rate power spectral analysis
US4862144A (en) * 1987-04-21 1989-08-29 Tao Billy S K Movement monitor
US5309916A (en) * 1990-07-18 1994-05-10 Avl Medical Instruments Ag Blood pressure measuring device and method
WO1996015713A1 (en) * 1994-11-24 1996-05-30 The Institute Of Respiratory Medicine Limited Biophysical foetus monitor
US5989193A (en) * 1995-05-19 1999-11-23 Somed Pty Limited Device and method for detecting and recording snoring
US6050950A (en) * 1996-12-18 2000-04-18 Aurora Holdings, Llc Passive/non-invasive systemic and pulmonary blood pressure measurement
US6547743B2 (en) * 1997-05-16 2003-04-15 Resmed Limited Respiratory-analysis systems

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10842701B2 (en) 2016-10-14 2020-11-24 Stryker Corporation Patient support apparatus with stabilization
US10339911B2 (en) 2016-11-01 2019-07-02 Stryker Corporation Person support apparatuses with noise cancellation

Also Published As

Publication number Publication date
US20120259179A1 (en) 2012-10-11
US6984207B1 (en) 2006-01-10
US20110066004A1 (en) 2011-03-17
US20060063982A1 (en) 2006-03-23
US20160157734A1 (en) 2016-06-09

Similar Documents

Publication Publication Date Title
US6984207B1 (en) Passive physiological monitoring (P2M) system
AU2002311781B2 (en) Passive physiological monitoring (P2M) system
US20230063373A1 (en) Method and apparatus for monitoring vital signs remotely
EP2124747B1 (en) Ballistocardiographic sensor system with a sensor arrangement and method of ballistocardiographic detection of body movements
US20070149883A1 (en) Method for detecting heart beat and determining heart and respiration rate
JP7093777B2 (en) A device for monitoring blood flow and respiratory flow
GB2319851A (en) Monitoring the physiological condition of a patient
Kurihara et al. Development of unconstrained heartbeat and respiration measurement system with pneumatic flow
CN101039618A (en) DVT detection
Sobhan et al. Data analysis methods for health monitoring sensors: a survey
Watanabe et al. In-bed biosignal acquisition from conventional differential pressure sensor based on thermal flow principle
Nishio et al. Development of a bed-based unconstrained cardiac auscultation method
Xu et al. A Low-Cost Non-Invasive Continuous Cardiovascular Monitoring System Based on Oil-Filled Rubber Tubing
Kitzig et al. Use of an automotive seat occupancy sensor for the functionalization of a nursing bed—An overview of the sensor and the possible applications in the clinic and care sector
Nakasho et al. Implementation of a vital signs monitoring system in combination with a bed-leaving detection system
Park et al. Self-diagnosis device using wrist pulse
Su et al. Ballistocardiogram measurement system using three load-cell sensors platform in chair
TW515703B (en) Sensor capable of simultaneously detecting electrocardiogram, pulse and sonic signals from neck
Jones et al. NASA contributions to cardiovascular monitoring
Hasnain et al. A ubiquitous real-time motion artifact rejection technique for remote NIBP monitoring of hypertensive patients
Ren Simultaneous pulse rate estimation for two individuals that share a sensor-laden bed
Han et al. Performance evaluation of biosignal measurement at the wheelchair system
Lidwina Posture Effect Examination During Respiration and Heart Rate Measurement Using a 10.5 GHz Doppler Radar
Liu et al. Review of sensors for remote patient monitoring
Barschdorff Information Processing of Biomedical Sensor Signatures for Ensuring the Quality of Life

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION